{"gene":"FGA","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1999,"finding":"Homozygous deletion of approximately 11 kb of the fibrinogen alpha-chain gene (FGA) causes complete absence of fibrinogen (congenital afibrinogenemia), establishing that FGA is required for fibrinogen synthesis and secretion in humans, analogous to findings in mice.","method":"Southern blotting, PCR, haplotype analysis of affected pedigree members","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — direct genetic loss-of-function with defined molecular and clinical phenotype, replicated across multiple independent chromosomes","pmids":["9916133"],"is_preprint":false},{"year":1999,"finding":"The recurrent 11 kb FGA deletion arises from non-homologous (illegitimate) recombination mediated by a 7 bp direct repeat (AACTTTT) located in FGA intron 1 and the FGA-FGB intergenic sequence, together with flanking inverted repeats that can form secondary structures.","method":"Nucleotide sequence analysis of deletion junctions, comparison with normal sequences, flanking polymorphic marker haplotyping","journal":"European journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 — direct sequencing of all three independent deletion junctions with mechanistic interpretation","pmids":["10602365"],"is_preprint":false},{"year":2001,"finding":"The most common congenital afibrinogenemia mutation, FGA IVS4+1G>T, causes aberrant mRNA splicing by activating multiple cryptic donor splice sites in exon 4 and intron 4; the predominant cryptic site (4 bp downstream) is used in 85% of transcripts, causing a frameshift and premature Aα-chain truncation (null allele).","method":"Transfection of normal and mutant minigene constructs into COS-7 cells, RT-PCR analysis of aberrant mRNA products","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — in vitro minigene splicing assay with molecular characterization of multiple aberrant transcripts","pmids":["11238133"],"is_preprint":false},{"year":2002,"finding":"The outcome of FGA donor splice-site mutations reflects the order of intron removal: intron 3 is spliced first, followed by intron 2, intron 4, and intron 1. Mutations in rapidly spliced introns (e.g., IVS3) predominantly cause exon skipping, while mutations in later-spliced introns (e.g., IVS4) lead to cryptic splice-site utilization or intron inclusion.","method":"Minigene transfection in COS-7 cells, RT-PCR analysis of splicing outcomes for IVS3delGTAA and IVS1+3A>G mutations","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — in vitro minigene assay with multiple mutations revealing mechanistic rule for splicing order","pmids":["12406899"],"is_preprint":false},{"year":1997,"finding":"Crystal structure of fibrinogen fragment D (from human fibrinogen) determined at 2.9 Å resolution, revealing a three-chained structure with a coiled-coil region and two homologous globular entities oriented ~130° to each other; the double-D fragment from fibrin, solved with a Gly-Pro-Arg-Pro-amide peptide ligand, defined the donor polymerization site.","method":"X-ray crystallography at 2.9 Å; molecular replacement for double-D","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional ligand (polymerization site peptide), foundational structural paper","pmids":["9333233"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of human fibrinogen determined at ~3.3 Å resolution, revealing the full hexameric (AαBβγ)₂ arrangement, coiled-coil regions with variable twist, an antiparallel β-chain interface, and prominent carbohydrate groups on β chains; αC domains were not resolvable.","method":"X-ray crystallography","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — direct crystal structure of full-length human fibrinogen","pmids":["19296670"],"is_preprint":false},{"year":1980,"finding":"Synthetic Gly-Pro-Arg peptides bind to fibrinogen and inhibit fibrin polymerization, defining the fibrin polymerization ('knob A') site on the Aα chain and establishing the structural requirements for donor-acceptor interactions in fibrin assembly.","method":"Synthetic peptide binding assays, fibrin polymerization inhibition, species-difference analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with defined structural requirements and multiple binding-site quantification","pmids":["7356959"],"is_preprint":false},{"year":1993,"finding":"Fibrinogen mediates leukocyte adhesion to vascular endothelium through a mechanism requiring ICAM-1 on endothelial cells; fibrinogen bridges leukocytes and endothelium by binding complementary receptors on both cell types, with ICAM-1 identified as a novel hematopoietic fibrinogen receptor by affinity chromatography and direct binding to recombinant protein.","method":"Affinity chromatography purification, genetically engineered ICAM-1 transfectants, direct binding assays, adhesion assays with blocking antibodies","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including receptor identification, transfectant validation, and direct binding to recombinant protein","pmids":["8100742"],"is_preprint":false},{"year":2002,"finding":"Fibrinogen alpha-chain (FGA) is a secreted glycoprotein phosphorylated at S-x-E motifs in the secretory pathway; Fam20C (Golgi casein kinase) phosphorylates FGA as part of the broader extracellular phosphoproteome.","method":"Mass spectrometry identification of phosphorylation sites; CRISPR/Cas9 Fam20C knockout followed by secreted phosphoproteome analysis","journal":"Science / Cell","confidence":"Medium","confidence_rationale":"Tier 2 — FGA identified as Fam20C substrate in large-scale phosphoproteomics with genetic validation, but FGA-specific functional consequences not individually characterized","pmids":["22582013","26091039"],"is_preprint":false},{"year":2002,"finding":"Misdiagnosis study established that fibrinogen Aα-chain (FGA) mutations are the most common cause of hereditary systemic amyloidosis misdiagnosed as AL amyloidosis, confirming that mutant FGA protein deposits as amyloid primarily in kidneys.","method":"Genetic screening for amyloidogenic mutations in 350 patients; histological and laboratory confirmation of hereditary amyloidosis","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 2 — systematic genetic and pathological characterization of 350 patients, multiple confirmatory investigations per patient","pmids":["12050338"],"is_preprint":false},{"year":2016,"finding":"Two familial FGA mutations associated with renal amyloidosis (E540V and R554L in the C-terminal αC-region fragment FGA(496-581)) enhance amyloidogenicity: E540V causes amyloid-like fibril formation and R554L causes globular β-sheet-rich aggregates at physiological pH, whereas wild-type FGA(496-581) remains monomeric.","method":"In vitro aggregation assays of recombinant FGA(496-581) fragments; atomic force microscopy (AFM); circular dichroism for β-sheet content","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution with AFM imaging; single lab, two mutations tested","pmids":["27126074"],"is_preprint":false},{"year":2010,"finding":"A novel nonsense mutation in FGA exon 5 (c.718C>T, p.Q240X) causes afibrinogenemia; expression of the mutant Aα-chain cDNA with wild-type Bβ and γ chains in COS-7 cells showed the truncated chain is produced but less efficiently secreted than wild-type, establishing that the Aα Q240X truncation impairs fibrinogen secretion rather than synthesis.","method":"COS-7 cell co-transfection of mutant and wild-type fibrinogen chain cDNAs; immunodetection in cell media","journal":"Blood coagulation & fibrinolysis","confidence":"Medium","confidence_rationale":"Tier 2 — functional expression assay directly testing secretion of mutant Aα chain","pmids":["20051841"],"is_preprint":false},{"year":2012,"finding":"A novel regulatory element (PFE2) located between FGA and FGG genes functions as a potent hepatocyte enhancer in both orientations; PFE2 enhances FGA promoter-driven gene expression in hepatoma cells and drives EGFP expression in transgenic zebrafish larval livers, identifying a cis-regulatory element controlling FGA transcription.","method":"Luciferase reporter assays in hepatoma cells; transgenic zebrafish GFP reporter assay; ChIP-seq data integration","journal":"Thrombosis and haemostasis","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo functional enhancer validation with multiple orientations tested","pmids":["22836734"],"is_preprint":false},{"year":2013,"finding":"siRNA-mediated knockdown of FGA mRNA by ~50% in HepG2 cells reduces secreted fibrinogen to only 78% of control, whereas equivalent knockdown of FGB or FGG reduces fibrinogen to 49% or 57%, demonstrating that FGA mRNA is present in excess relative to FGB and FGG, and that FGG mRNA is the rate-limiting component for fibrinogen expression in normal liver.","method":"siRNA knockdown of individual fibrinogen chains in HepG2 cells; quantitative RT-PCR for mRNA levels; ELISA for secreted fibrinogen","journal":"Thrombosis research","confidence":"Medium","confidence_rationale":"Tier 2 — systematic siRNA knockdown of each chain with quantitative output, revealing stoichiometric regulation","pmids":["23414568"],"is_preprint":false},{"year":2014,"finding":"Zinc finger nuclease-mediated frameshift mutations in zebrafish fga produce homozygous fish with undetectable plasma fibrinogen, hemorrhaging, and reduced survival, validating fga as the causative locus for afibrinogenemia and establishing the first transmissible zebrafish model of this human bleeding disorder.","method":"Zinc finger nuclease gene targeting; anti-fibrinogen antibody detection in plasma; hemorrhage phenotype scoring; survival analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic knockout model with multiple independent alleles and defined molecular and phenotypic readouts","pmids":["24553182"],"is_preprint":false},{"year":2014,"finding":"Lentiviral transduction of the human FGA cDNA into hepatocytes from an afibrinogenemia patient (homozygous FGA deletion) restores Aα-chain expression and secretion of fully functional fibrinogen hexamer in vitro, demonstrating that gene delivery of FGA alone is sufficient for functional fibrinogen assembly and secretion.","method":"Lentiviral vector transduction of patient-derived hepatocytes; functional fibrinogen assays in conditioned media","journal":"Journal of thrombosis and haemostasis","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional rescue experiment in patient-derived cells","pmids":["25163824"],"is_preprint":false},{"year":2016,"finding":"The FGA variant c.169_180+2 del (fibrinogen Shanghai) causes exon 2 skipping, producing a shortened Aα chain with 42 N-terminal amino acid truncation; patient fibrinogen shows impaired fibrinopeptide A release by thrombin, prolonged polymerization lag time, slower maximum slope, reduced final turbidity, and thicker fibres with looser clot network by scanning electron microscopy, without affecting fibrinogen synthesis or secretion.","method":"FGA minigene transfection splicing assay; turbidimetric fibrin polymerization and lysis assays; reversed-phase HPLC for fibrinopeptide release; scanning electron microscopy of fibrin clots","journal":"Journal of clinical pathology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal biochemical and structural methods characterizing functional consequences of the Aα N-terminal truncation","pmids":["27555433"],"is_preprint":false},{"year":2017,"finding":"The FGA mutation p.Arg104Cys (g.3057C>T) causes hypodysfibrinogenemia; mass spectrometry (TOF-MS) showed the variant Aα chain represents only ~25% of total circulating Aα chain, indicating impaired secretion of the mutant chain. Plasmin degradation and fibrinogen-albumin complex formation were normal, while clot structure was nearly normal by confocal microscopy.","method":"Reverse phase-electrospray TOF-MS for chain quantification; turbidimetric polymerization; immunoblotting for albumin complexes; confocal microscopy of clot structure; SDS-PAGE of plasmin degradation products","journal":"BMC hematology","confidence":"Medium","confidence_rationale":"Tier 1–2 — direct quantification of mutant chain secretion by MS with multiple functional assays","pmids":["29299315"],"is_preprint":false},{"year":2022,"finding":"Mice carrying the Fga270 premature termination codon (at residue 271, within the αC-region) are hypofibrinogenemic (~10% plasma fibrinogen) due to nonsense-mediated decay of mutant Fga mRNA (90% reduction in hepatic mRNA); despite low plasma fibrinogen, these mice have preserved hemostasis in tail bleeding and laser-injury models, normal initial platelet aggregation, and are fully protected from venous thrombosis (IVC stasis model). Platelet fibrinogen is ~30% of wild-type with compensatory fibronectin increase, revealing that αC-region truncation selectively reduces plasma but partially preserves platelet fibrinogen.","method":"Targeted mouse knock-in; plasma fibrinogen ELISA; hepatic mRNA quantification; tail bleeding assay; laser-induced saphenous vein injury; IVC stasis thrombosis model; platelet aggregometry; platelet fibrinogen and fibronectin quantification; S. aureus peritonitis survival model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple in vivo and in vitro orthogonal methods across hemostasis, thrombosis, and infection models with mechanistic explanation (NMD, platelet compensation)","pmids":["34905618"],"is_preprint":false},{"year":2022,"finding":"FGA (fibrinogen alpha chain) knockdown in endometrial stromal cells reduces VEGFA, PDGF, FGF-B, MMP-2, and MMP-9 expression, and the conditioned medium from FGA-knockdown cells inhibits HUVEC tube formation, migration, VE-cadherin expression, microfilament formation, and suppresses VEGFR2 and FAK signaling, establishing that FGA promotes angiogenesis via a VEGFA-VEGFR2-FAK signaling axis.","method":"FGA siRNA knockdown in endometrial stromal cells; conditioned medium transfer to HUVECs; tube formation assay; wound/transwell migration assays; matrigel plug assay in vivo; Western blotting for VEGFR2/FAK phosphorylation; immunofluorescence for F-actin/VE-cadherin","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2–3 — conditioned medium approach with multiple functional readouts and pathway validation, single lab","pmids":["35498401"],"is_preprint":false},{"year":2022,"finding":"FGA overexpression in gastric cancer cells suppresses ITGA5 (Integrin-α5) transcription (confirmed by luciferase and ChIP assays), inhibits FAK/ERK pathway activity, suppresses migration, invasion, EMT, and induces autophagy; FGA knockout activates FAK/ERK and promotes tumor growth in nude mouse xenografts.","method":"FGA overexpression/knockout cell models; transwell and wound healing assays; luciferase reporter and ChIP assays for ITGA5 transcription; Western blotting for FAK/ERK; RFP-GFP-LC3 autophagy assay; in vivo xenograft","journal":"Tissue & cell","confidence":"Medium","confidence_rationale":"Tier 2 — luciferase + ChIP establish transcriptional mechanism; FAK/ERK pathway placement by loss-of-function with multiple readouts","pmids":["35257941"],"is_preprint":false},{"year":2024,"finding":"FGA overexpression in hepatocellular carcinoma cells increases E-cadherin and decreases N-cadherin and Slug (EMT markers), inhibits cell migration and invasion; FGA knockout activates the PI3K/AKT pathway, and FGA overexpression restricts tumor spread in a mouse metastasis model.","method":"FGA overexpression and knockout cell models; Transwell migration/invasion assays; wound healing assay; Western blotting for EMT markers and PI3K/AKT; in vivo mouse metastasis model","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2–3 — genetic loss- and gain-of-function with pathway placement (PI3K/AKT) and in vivo validation, single lab","pmids":["39227068"],"is_preprint":false},{"year":2023,"finding":"Computational modeling and in vitro aggregation experiments show that vitamin C and vitamin D3 interact with amyloidogenic sites of E524K and E526K FGA C-terminal mutants, reducing amyloid fibril formation; Congo red assays, aggregation index measurements, and AFM imaging confirm smaller aggregates in the presence of vitamin D3.","method":"Molecular docking; MD simulation-derived binding free energy; Congo red absorbance; aggregation index; AFM imaging of aggregates","journal":"The Journal of steroid biochemistry and molecular biology","confidence":"Low","confidence_rationale":"Tier 3–4 — primarily computational with limited in vitro confirmation; no structural or mechanistic validation beyond aggregate size","pmids":["36907427"],"is_preprint":false},{"year":2025,"finding":"FGA expression in granulosa cells is regulated by histone acetylation: HDAC2 knockdown reduces chromatin accessibility and H3K9ac enrichment at the FGA promoter region (-1350/-1454 bp), suppressing FGA transcription. FGA promotes granulosa cell proliferation and cell cycle progression (upregulating PCNA and CCNE1) and inhibits apoptosis (suppressing Caspase3 and Caspase9) both in vitro and in vivo, advancing pubertal initiation in mice.","method":"HDAC1/2/3 siRNA knockdown; ATAC-seq for chromatin accessibility; ChIP for H3K9ac at FGA promoter; FGA knockdown/overexpression in granulosa cells; flow cytometry for cell cycle/apoptosis; Western blotting for PCNA, CCNE1, Caspase3/9; in vivo mouse model for corpora lutea and estradiol","journal":"Biological research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP + ATAC-seq establish epigenetic mechanism; multiple functional readouts in vitro and in vivo, single lab","pmids":["40605115"],"is_preprint":false},{"year":2012,"finding":"A minigene corresponding to the FGAΔ1238 deletion generates two aberrant mRNAs with frameshifts causing premature termination; the FGA c.54+3A>C substitution activates a cryptic 5' splice site in exon 1, producing one transcript with a frameshift and another deleting six amino acids from the signal peptide, both predicted to impair Aα-chain assembly/secretion.","method":"Minigene cloning and transfection into CHO cells; RT-PCR and sequencing of aberrant mRNAs","journal":"International journal of hematology","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro minigene splicing assay with molecular characterization of aberrant transcripts","pmids":["22639050"],"is_preprint":false},{"year":2012,"finding":"A mutation of the FGA translation initiation codon (c.1A>T, M1L) causes congenital afibrinogenemia, establishing that the canonical ATG start codon is essential for Aα-chain translation and hence fibrinogen synthesis.","method":"PCR amplification and Sanger sequencing of all FGA exons; compound heterozygosity with FGA c.385C>T (R129X) in a patient with afibrinogenemia","journal":"Blood coagulation & fibrinolysis","confidence":"Medium","confidence_rationale":"Tier 2 — genetic identification of start codon mutation; functional null established by complete fibrinogen absence","pmids":["22732251"],"is_preprint":false}],"current_model":"FGA encodes the fibrinogen Aα chain, which is synthesized in hepatocytes under transcriptional control of a liver enhancer (PFE2) and HDAC2-regulated H3K9ac at its promoter; FGA mRNA is present in stoichiometric excess over FGB and FGG (with FGG being rate-limiting), and the Aα chain assembles with Bβ and γ chains into the (AαBβγ)₂ hexamer whose crystal structure (2.9–3.3 Å) reveals a coiled-coil scaffold with globular D-domains harboring the 'knob A' (Gly-Pro-Arg) polymerization site; upon thrombin cleavage of fibrinopeptide A, fibrin polymerization proceeds through knob-hole interactions whose structural requirements are defined by synthetic peptide inhibition studies; the αC-region (residues ~271 onward) is required for normal plasma fibrinogen levels (its truncation triggers nonsense-mediated mRNA decay and reduces circulating fibrinogen ~90%) but is dispensable for hemostasis and bacterial clearance at ~10% fibrinogen; fibrinogen bridges leukocytes to endothelium via ICAM-1; familial αC-region mutations (E540V, R554L) increase amyloidogenicity and cause renal amyloid deposition; in non-hepatic contexts FGA suppresses cancer cell invasion by transcriptionally repressing ITGA5/FAK/ERK and PI3K/AKT signaling, and promotes angiogenesis in endometrial stromal cells via a VEGFA-VEGFR2-FAK axis."},"narrative":{"teleology":[{"year":1980,"claim":"Defining the structural basis of fibrin polymerization initiation: synthetic Gly-Pro-Arg peptides established that the newly exposed Aα N-terminus constitutes the 'knob A' donor site and defined the minimal sequence requirements for knob–hole interaction.","evidence":"Synthetic peptide binding and fibrin polymerization inhibition assays using purified fibrinogen","pmids":["7356959"],"confidence":"High","gaps":["Acceptor (hole) site structure not yet resolved","In vivo relevance of peptide inhibition not tested","Contribution of knob B not addressed"]},{"year":1993,"claim":"Establishing fibrinogen as a vascular adhesion bridge: fibrinogen was shown to mediate leukocyte–endothelial adhesion by engaging ICAM-1 as a novel fibrinogen receptor, expanding the Aα chain's role beyond coagulation to inflammation.","evidence":"Affinity chromatography, ICAM-1 transfectant binding assays, and adhesion blocking antibody experiments","pmids":["8100742"],"confidence":"High","gaps":["Binding site on Aα chain for ICAM-1 not mapped","Relative contribution of Aα vs. Bβ/γ chains to ICAM-1 interaction unknown","In vivo leukocyte trafficking consequences not tested"]},{"year":1997,"claim":"Resolving the three-dimensional architecture of fibrinogen's functional domains: the crystal structure of fragment D and the double-D:Gly-Pro-Arg-Pro complex revealed the coiled-coil scaffold, globular D-domain topology, and the structural basis of knob–hole polymerization.","evidence":"X-ray crystallography at 2.9 Å resolution with polymerization-site peptide ligand","pmids":["9333233"],"confidence":"High","gaps":["Full-length hexamer structure not yet available","αC-region structure unresolved","Dynamic conformational changes during polymerization not captured"]},{"year":1999,"claim":"Proving FGA is essential for fibrinogen biogenesis in humans: an 11 kb homozygous FGA deletion was identified as the cause of congenital afibrinogenemia, and the deletion mechanism was traced to illegitimate recombination at a 7 bp direct repeat.","evidence":"Southern blotting, PCR, haplotype analysis of pedigrees; deletion junction sequencing across three independent chromosomes","pmids":["9916133","10602365"],"confidence":"High","gaps":["Contribution of individual FGA domains to intracellular assembly not dissected","Non-hepatic consequences of complete FGA loss not explored"]},{"year":2001,"claim":"Elucidating how FGA splice-site mutations produce null alleles: the most common afibrinogenemia mutation (IVS4+1G>T) activates cryptic splice donors causing frameshifts, and intron removal order determines whether a splice mutation causes exon skipping or cryptic-site usage.","evidence":"Minigene transfection in COS-7 cells with RT-PCR characterization of multiple mutations (IVS4, IVS3, IVS1)","pmids":["11238133","12406899"],"confidence":"High","gaps":["Nonsense-mediated decay contribution not quantified at this stage","Patient-to-patient variation in aberrant transcript ratios not assessed"]},{"year":2002,"claim":"Identifying FGA mutations as the leading cause of hereditary renal amyloidosis: systematic screening of 350 patients revealed that Aα C-terminal variants are the most common genetic cause of systemic amyloidosis misdiagnosed as AL type.","evidence":"Genetic screening with histological and laboratory confirmation across a large patient cohort","pmids":["12050338"],"confidence":"High","gaps":["Mechanism by which αC variants convert to amyloid fibrils not established at molecular level","Tissue tropism for kidney not explained"]},{"year":2009,"claim":"Completing the hexameric fibrinogen structure: the full-length (AαBβγ)₂ crystal structure at 3.3 Å confirmed the coiled-coil arrangement, β-chain carbohydrate positions, and an antiparallel β-chain interface, though the αC domains remained unresolved.","evidence":"X-ray crystallography of intact human fibrinogen","pmids":["19296670"],"confidence":"High","gaps":["αC-region remains structurally unresolved","No structure of fibrinogen in complex with thrombin or cellular receptors"]},{"year":2012,"claim":"Defining cis-regulatory and mRNA-level control of FGA expression: the PFE2 enhancer was validated as a hepatocyte-specific element driving FGA transcription, and siRNA experiments demonstrated that FGA mRNA is in stoichiometric excess, with FGG being rate-limiting for fibrinogen secretion.","evidence":"Luciferase reporter assays in hepatoma cells; transgenic zebrafish GFP reporter; siRNA knockdown of each fibrinogen chain in HepG2 with secreted fibrinogen ELISA","pmids":["22836734","23414568"],"confidence":"Medium","gaps":["Transcription factor(s) binding PFE2 not identified","Post-transcriptional regulation of chain stoichiometry not addressed","In vivo validation of stoichiometric excess in human liver lacking"]},{"year":2014,"claim":"Demonstrating FGA sufficiency for fibrinogen rescue: lentiviral delivery of FGA cDNA into afibrinogenemia patient hepatocytes restored functional hexamer secretion, and zebrafish fga knockouts recapitulated human afibrinogenemia with hemorrhage and lethality.","evidence":"Lentiviral transduction of patient hepatocytes with fibrinogen functional assays; zinc finger nuclease knockout zebrafish with hemorrhage scoring and survival analysis","pmids":["25163824","24553182"],"confidence":"High","gaps":["In vivo gene therapy efficacy and durability not assessed","Long-term hemostatic function in zebrafish not followed"]},{"year":2016,"claim":"Establishing molecular mechanisms of amyloidogenic αC-region variants: in vitro aggregation of recombinant FGA(496-581) showed that E540V forms amyloid-like fibrils and R554L forms β-sheet-rich aggregates at physiological pH, while wild-type remains monomeric, directly linking point mutations to pathological misfolding.","evidence":"Recombinant fragment aggregation assays with AFM imaging and circular dichroism","pmids":["27126074"],"confidence":"Medium","gaps":["Nucleation mechanism and kinetics not determined","Kidney-specific amyloid deposition not explained","No structural model of fibril at atomic resolution"]},{"year":2022,"claim":"Uncoupling the αC-region from essential hemostatic function: mice with a premature stop at Aα residue 271 had ~10% plasma fibrinogen (via NMD) yet showed normal hemostasis, preserved platelet fibrinogen with compensatory fibronectin, and full protection from venous thrombosis—demonstrating that the αC-region is dispensable for hemostasis but critical for maintaining plasma fibrinogen levels.","evidence":"Targeted knock-in mouse; tail bleeding, laser injury, IVC stasis thrombosis, bacterial peritonitis models; platelet proteomics","pmids":["34905618"],"confidence":"High","gaps":["Mechanism of platelet fibrinogen preservation not fully explained","αC-region contribution to fibrin clot mechanical properties in vivo not tested","Wound healing and tissue repair outcomes not evaluated"]},{"year":2022,"claim":"Revealing non-hemostatic signaling roles of FGA: in cancer cells, FGA represses ITGA5 transcription (via promoter binding) to suppress FAK/ERK signaling, migration, and invasion; in hepatocellular carcinoma, FGA loss activates PI3K/AKT; and in endometrial stromal cells, FGA promotes angiogenesis through a VEGFA-VEGFR2-FAK axis.","evidence":"FGA overexpression/knockout in gastric and hepatocellular carcinoma cells with ChIP, luciferase, xenograft models; siRNA in endometrial stromal cells with conditioned medium HUVEC assays","pmids":["35257941","39227068","35498401"],"confidence":"Medium","gaps":["Whether circulating fibrinogen or locally produced Aα chain mediates these effects is unclear","Direct DNA-binding domain of FGA not identified","Relevance to in vivo tumor biology in patients not established"]},{"year":2025,"claim":"Linking epigenetic regulation to FGA's role in reproductive biology: HDAC2 was shown to control chromatin accessibility and H3K9ac at the FGA promoter in granulosa cells, where FGA promotes proliferation and suppresses apoptosis to support pubertal initiation.","evidence":"HDAC2 siRNA, ATAC-seq, ChIP for H3K9ac, FGA knockdown/overexpression in granulosa cells, in vivo mouse puberty model","pmids":["40605115"],"confidence":"Medium","gaps":["Whether FGA functions intracellularly or as a secreted factor in granulosa cells is unknown","Relationship between granulosa FGA and circulating fibrinogen not addressed","Upstream signals regulating HDAC2 at FGA promoter not identified"]},{"year":null,"claim":"Key unresolved questions include: the atomic structure of the αC-region and the structural basis of its amyloidogenic conversion; the mechanism by which FGA represses gene transcription (e.g., ITGA5) in non-hepatic cells; and whether therapeutic reduction of αC-region length can prevent thrombosis without hemostatic compromise in humans.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of the αC domain","No identified DNA-binding or transcription-regulatory domain in FGA","Clinical translation of αC-truncation antithrombotic strategy untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[4,5,6]},{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[7]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[7,19]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[4,5,6,7,8,18]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[0,4,5,6,14,16,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,10]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[19,20,21]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[7]}],"complexes":["Fibrinogen (AαBβγ)₂ hexamer"],"partners":["FGB","FGG","ICAM1","ITGA5","VEGFR2","FAK","HDAC2"],"other_free_text":[]},"mechanistic_narrative":"FGA encodes the fibrinogen Aα chain, an essential subunit of the (AαBβγ)₂ hexameric fibrinogen complex that is assembled in hepatocytes and secreted into plasma, where thrombin cleavage of fibrinopeptide A exposes the 'knob A' (Gly-Pro-Arg) polymerization site to initiate fibrin clot formation [PMID:7356959, PMID:9333233, PMID:19296670]. Loss-of-function mutations in FGA—including large deletions, splice-site mutations, and start-codon disruption—cause congenital afibrinogenemia, while missense mutations in the αC-region (e.g., E540V, R554L) confer amyloidogenicity and underlie hereditary renal amyloidosis, the most commonly misdiagnosed form of systemic amyloidosis [PMID:9916133, PMID:12050338, PMID:27126074]. FGA transcription in hepatocytes is driven by the PFE2 liver enhancer and regulated by HDAC2-dependent H3K9 acetylation at its promoter; FGA mRNA is produced in stoichiometric excess over FGB and FGG, with the γ chain being rate-limiting for fibrinogen secretion [PMID:22836734, PMID:23414568, PMID:40605115]. Beyond hemostasis, fibrinogen bridges leukocytes to endothelium via ICAM-1, and ectopic FGA expression suppresses cancer cell invasion by repressing ITGA5/FAK/ERK and PI3K/AKT signaling [PMID:8100742, PMID:35257941, PMID:39227068]."},"prefetch_data":{"uniprot":{"accession":"P02671","full_name":"Fibrinogen alpha chain","aliases":[],"length_aa":866,"mass_kda":95.0,"function":"Cleaved by the protease thrombin to yield monomers which, together with fibrinogen beta (FGB) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using anticoagulated blood. However, subsequent studies have shown that it is not absolutely required for thrombus formation in vivo. Enhances expression of SELP in activated platelets via an ITGB3-dependent pathway. Maternal fibrinogen is essential for successful pregnancy. Fibrin deposition is also associated with infection, where it protects against IFNG-mediated hemorrhage. May also facilitate the immune response via both innate and T-cell mediated pathways","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P02671/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FGA","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SRP14","stoichiometry":0.2},{"gene":"WIPF2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/FGA","total_profiled":1310},"omim":[{"mim_id":"616004","title":"DYSFIBRINOGENEMIA, CONGENITAL","url":"https://www.omim.org/entry/616004"},{"mim_id":"613378","title":"AIG2-LIKE DOMAIN-CONTAINING PROTEIN 1; A2LD1","url":"https://www.omim.org/entry/613378"},{"mim_id":"610784","title":"MICRO RNA 29C; MIR29C","url":"https://www.omim.org/entry/610784"},{"mim_id":"610783","title":"MICRO RNA 29B1; MIR29B1","url":"https://www.omim.org/entry/610783"},{"mim_id":"610782","title":"MICRO RNA 29A; MIR29A","url":"https://www.omim.org/entry/610782"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Endoplasmic reticulum","reliability":"Enhanced"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"liver","ntpm":17201.5}],"url":"https://www.proteinatlas.org/search/FGA"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P02671","domains":[{"cath_id":"3.90.215.10","chopping":"633-863","consensus_level":"high","plddt":91.6616,"start":633,"end":863},{"cath_id":"1.20.5","chopping":"71-180_194-213","consensus_level":"high","plddt":80.7542,"start":71,"end":213}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P02671","model_url":"https://alphafold.ebi.ac.uk/files/AF-P02671-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P02671-F1-predicted_aligned_error_v6.png","plddt_mean":60.34},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FGA","jax_strain_url":"https://www.jax.org/strain/search?query=FGA"},"sequence":{"accession":"P02671","fasta_url":"https://rest.uniprot.org/uniprotkb/P02671.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P02671/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P02671"}},"corpus_meta":[{"pmid":"9916133","id":"PMC_9916133","title":"Deletion of the fibrinogen [correction of fibrogen] alpha-chain gene (FGA) causes congenital afibrogenemia.","date":"1999","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9916133","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11354637","id":"PMC_11354637","title":"Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes.","date":"2001","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11354637","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12406899","id":"PMC_12406899","title":"Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA).","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12406899","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35498401","id":"PMC_35498401","title":"FGA Controls VEGFA Secretion to Promote Angiogenesis by Activating the VEGFR2-FAK Signalling Pathway.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35498401","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29719494","id":"PMC_29719494","title":"Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer.","date":"2018","source":"Clinical proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/29719494","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11197626","id":"PMC_11197626","title":"A Korean population study of the nine STR loci FGA, VWA, D3S1358, D18S51, D21S11, D8S1179, D7S820, D13S317 and D5S818.","date":"2000","source":"International journal of legal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11197626","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11238133","id":"PMC_11238133","title":"Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G-->T.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11238133","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24553182","id":"PMC_24553182","title":"Targeted mutation of zebrafish fga models human congenital afibrinogenemia.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24553182","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34905618","id":"PMC_34905618","title":"Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34905618","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32967043","id":"PMC_32967043","title":"Serum sCD14, PGLYRP2 and FGA as potential biomarkers for multidrug-resistant tuberculosis based on data-independent acquisition and targeted proteomics.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32967043","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10602365","id":"PMC_10602365","title":"The 11 kb FGA deletion responsible for congenital afibrinogenaemia is mediated by a short direct repeat in the fibrinogen gene cluster.","date":"1999","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/10602365","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16362348","id":"PMC_16362348","title":"Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16362348","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9153779","id":"PMC_9153779","title":"Report of the European DNA profiling group (EDNAP): an investigation of the complex STR loci D21S11 and HUMFIBRA (FGA).","date":"1997","source":"Forensic science international","url":"https://pubmed.ncbi.nlm.nih.gov/9153779","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27126074","id":"PMC_27126074","title":"Familial mutations in fibrinogen Aα (FGA) chain identified in renal amyloidosis increase in vitro amyloidogenicity of FGA fragment.","date":"2016","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/27126074","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35257941","id":"PMC_35257941","title":"FGA inhibits metastases and induces autophagic cell death in gastric cancer via inhibiting ITGA5 to regulate the FAK/ERK pathway.","date":"2022","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/35257941","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27266621","id":"PMC_27266621","title":"Ischemic Stroke and Six Genetic Variants in CRP, EPHX2, FGA, and NOTCH3 Genes: A Meta-Analysis.","date":"2016","source":"Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","url":"https://pubmed.ncbi.nlm.nih.gov/27266621","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22836734","id":"PMC_22836734","title":"A novel regulatory element between the human FGA and FGG genes.","date":"2012","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/22836734","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17316238","id":"PMC_17316238","title":"A single mutation in the FGA locus responsible for false homozygosities and discrepancies between commercial kits in an unusual paternity test case.","date":"2007","source":"Journal of forensic sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17316238","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31776635","id":"PMC_31776635","title":"FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma.","date":"2019","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/31776635","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39227068","id":"PMC_39227068","title":"FGA influences invasion and metastasis of hepatocellular carcinoma through the PI3K/AKT pathway.","date":"2024","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/39227068","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35757752","id":"PMC_35757752","title":"Serum Proteomic Analysis Identifies SAA1, FGA, SAP, and CETP as New Biomarkers for Eosinophilic Granulomatosis With Polyangiitis.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35757752","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26676819","id":"PMC_26676819","title":"Hepatic Fibrinogen Storage Disease in a Patient with Hypofibrinogenemia: Report of a Case with a Missense Mutation of the FGA Gene.","date":"2015","source":"Seminars in liver disease","url":"https://pubmed.ncbi.nlm.nih.gov/26676819","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15027538","id":"PMC_15027538","title":"Accurate STR allele designations at the FGA and vWA loci despite primer site polymorphisms.","date":"2004","source":"Journal of forensic sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15027538","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29067075","id":"PMC_29067075","title":"A Chinese family with congenital Dysfibrinogenemia carries a heterozygous missense mutation in FGA: Concerning the genetic abnormality and clinical treatment.","date":"2017","source":"Pakistan journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29067075","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21245743","id":"PMC_21245743","title":"A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family.","date":"2011","source":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/21245743","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20051841","id":"PMC_20051841","title":"Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients.","date":"2010","source":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/20051841","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22732251","id":"PMC_22732251","title":"Mutation of the translation initiation codon in FGA causes congenital afibrinogenemia.","date":"2012","source":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/22732251","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17083511","id":"PMC_17083511","title":"Identification of three FGA mutations in two Chinese families with congenital afibrinogenaemia.","date":"2006","source":"Haemophilia : the official journal of the World Federation of Hemophilia","url":"https://pubmed.ncbi.nlm.nih.gov/17083511","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23414568","id":"PMC_23414568","title":"siRNA down-regulation of FGA mRNA in HepG2 cells demonstrated that heterozygous abnormality of the Aα-chain gene does not affect the plasma fibrinogen level.","date":"2013","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/23414568","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19417632","id":"PMC_19417632","title":"A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream.","date":"2009","source":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/19417632","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9780514","id":"PMC_9780514","title":"Population genetic characteristics of the STR Loci D21S11 and FGA in eight diverse human populations.","date":"1998","source":"Human biology","url":"https://pubmed.ncbi.nlm.nih.gov/9780514","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10460432","id":"PMC_10460432","title":"Genetic data on three complex STRs (ACTBP2, D21S11 and HUMFIBRA/FGA) in the Galician population (NW Spain).","date":"1999","source":"International journal of legal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10460432","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29122299","id":"PMC_29122299","title":"Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis.","date":"2017","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/29122299","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37575991","id":"PMC_37575991","title":"Association between FGA gene polymorphisms and coronary artery lesion in Kawasaki disease.","date":"2023","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37575991","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15242750","id":"PMC_15242750","title":"Sexual differentiation traits in functional males with female genital apertures (male symbol fga) in the woodlice Armadillidium vulgare Latr. (Isopoda, Crustacea).","date":"2004","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15242750","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38708173","id":"PMC_38708173","title":"Factor VII R353Q (rs6046), FGA A6534G (rs6050), and FGG C10034T (rs2066865) Gene Polymorphisms and Risk of Recurrent Pregnancy Loss in Iranian Women.","date":"2023","source":"Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion","url":"https://pubmed.ncbi.nlm.nih.gov/38708173","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21030286","id":"PMC_21030286","title":"Identification of dual false indirect exclusions on the D5S818 and FGA loci.","date":"2010","source":"Legal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/21030286","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33374030","id":"PMC_33374030","title":"Analysis of an Inherited Dysfibrinogenemia Pedigree Associated with a Heterozygous Mutation in the FGA Gene.","date":"2020","source":"Hamostaseologie","url":"https://pubmed.ncbi.nlm.nih.gov/33374030","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15795544","id":"PMC_15795544","title":"A novel nonsense mutation in the FGA gene in a Chinese family with congenital afibrinogenaemia.","date":"2005","source":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/15795544","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27555433","id":"PMC_27555433","title":"Dysfibrinogenemia-associated novel heterozygous mutation, Shanghai (FGA c.169_180+2 del), leads to N-terminal truncation of fibrinogen Aα chain and impairs fibrin polymerization.","date":"2016","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27555433","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25163824","id":"PMC_25163824","title":"In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patient's hepatocytes.","date":"2014","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/25163824","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9813453","id":"PMC_9813453","title":"The short tandem repeat loci hTPO, THO1 and FGA.","date":"1998","source":"Human heredity","url":"https://pubmed.ncbi.nlm.nih.gov/9813453","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24192574","id":"PMC_24192574","title":"Association of the FGA and SLC6A4 genes with autistic spectrum disorder in a Korean population.","date":"2013","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24192574","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25979606","id":"PMC_25979606","title":"Multistep microsatellite mutation leading to father-child mismatch of FGA locus in a case of non-exclusion parentage.","date":"2015","source":"Legal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/25979606","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30290666","id":"PMC_30290666","title":"A novel fibrinogen variant in a Chinese pedigree with congenital dysfibrinogenemia caused by FGA P. Arg38Thr mutation: A case report.","date":"2018","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30290666","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39130639","id":"PMC_39130639","title":"Glycerophosphoinositol modulates FGA and NOTCH3 in exercise-induced muscle adaptation and colon cancer progression.","date":"2024","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39130639","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22639050","id":"PMC_22639050","title":"Molecular analysis of afibrinogenemic mutations caused by a homozygous FGA1238 bp deletion, and a compound heterozygous FGA1238 bp deletion and novel FGA c.54+3A>C substitution.","date":"2012","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/22639050","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31725541","id":"PMC_31725541","title":"A Novel Frameshift Mutation in the FGA Gene (c.196 delT) Leading to Congenital Afibrinogenemia.","date":"2020","source":"Journal of pediatric hematology/oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31725541","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35685547","id":"PMC_35685547","title":"A Case of Type 1 Triallelic Patterns at D5S818, D18S51, D6S1043, and FGA Demonstrated by Short Tandem Repeat Analysis.","date":"2022","source":"International journal of clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/35685547","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31198450","id":"PMC_31198450","title":"The Relationship between Gene Polymorphism of miRNAs Regulating FGA and Schizophrenia.","date":"2019","source":"Open access Macedonian journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31198450","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36813871","id":"PMC_36813871","title":"Germline VWF/MPRIP and somatoplasm FGA variants synergically confer susceptibility to non-traumatic osteonecrosis of the femoral head.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36813871","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36907427","id":"PMC_36907427","title":"Selective vitamins as potential options for dietary therapeutic interventions: In silico and In vitro insights from mutant C terminal fragment of FGA.","date":"2023","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36907427","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30881084","id":"PMC_30881084","title":"c.259A>C in the fibrinogen gene of alpha chain (FGA) is a fibrinogen with thrombotic phenotype.","date":"2019","source":"The application of clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30881084","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35250392","id":"PMC_35250392","title":"Positron Emission Tomography (PET) with 18F-FGA for Diagnosis of Myocardial Infarction in a Coronary Artery Ligation Model.","date":"2022","source":"Molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/35250392","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29299315","id":"PMC_29299315","title":"A novel fibrinogen mutation: FGA g. 3057 C > T (p. Arg104 > Cys) impairs fibrinogen secretion.","date":"2017","source":"BMC hematology","url":"https://pubmed.ncbi.nlm.nih.gov/29299315","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34356081","id":"PMC_34356081","title":"An FGA Frameshift Variant Associated with Afibrinogenemia in Dachshunds.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34356081","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28144929","id":"PMC_28144929","title":"Population database on: D1S1656, D2S441, D2S1338, D3S1358, D8S1179, D10S1248, D22S1045, D12S391, D16S539, D18S51, D19S433, D21S11, FGA, TH01, vWA loci included in NGM system based on one thousand unrelated individuals from Lodz region of Central Poland.","date":"2016","source":"Archiwum medycyny sadowej i kryminologii","url":"https://pubmed.ncbi.nlm.nih.gov/28144929","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23201233","id":"PMC_23201233","title":"A hypervariable STR polymorphism in the CFI gene: mutation rate and no linkage disequilibrium with FGA.","date":"2012","source":"Legal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/23201233","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31515786","id":"PMC_31515786","title":"[Analysis of a pedigree affected with congenital dysfibrinogenemia due to a novel Gly31Glu mutation of FGA gene].","date":"2019","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31515786","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33336034","id":"PMC_33336034","title":"A family study of congenital dysfibrinogenemia caused by a novel mutation in the FGA gene: A case report.","date":"2020","source":"Open medicine (Warsaw, Poland)","url":"https://pubmed.ncbi.nlm.nih.gov/33336034","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32228225","id":"PMC_32228225","title":"Congenital fibrinogen disorder caused by digenic mutations of the FGA and FGB genes.","date":"2020","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/32228225","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15946522","id":"PMC_15946522","title":"[Congenital afibrinogenemia associated with a novel nonsense mutation in the FGA gene].","date":"2005","source":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/15946522","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19698251","id":"PMC_19698251","title":"[Genetic analysis of an inherited afibrinogenemia family caused by a novel frameshift mutation in FGA].","date":"2009","source":"Zhongguo shi yan xue ye xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/19698251","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32659604","id":"PMC_32659604","title":"Population-dependent migration shift caused by sequence variation at the alpha fibrinogen (FGA) short tandem repeat (STR) locus.","date":"2020","source":"Forensic science international","url":"https://pubmed.ncbi.nlm.nih.gov/32659604","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17349757","id":"PMC_17349757","title":"Allele frequencies for nine STR loci (D3S1358, vWA, FGA, D8S1179, D21S11, D18S51, D5S818, D13S317, D7S820) in the Italian population.","date":"2007","source":"Forensic science international","url":"https://pubmed.ncbi.nlm.nih.gov/17349757","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24605994","id":"PMC_24605994","title":"Analysis of positive control STR experiments reveals that results obtained for FGA, D3S1358, and D13S317 condition the success rate of the analysis of routine reference samples.","date":"2014","source":"Journal of forensic sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24605994","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40605115","id":"PMC_40605115","title":"FGA, a new target of histone acetylation, inhibits apoptosis of granulosa cells in follicles.","date":"2025","source":"Biological research","url":"https://pubmed.ncbi.nlm.nih.gov/40605115","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26186693","id":"PMC_26186693","title":"Concurrent copy number variations on chromosome 8 and 22 combined with mutation at FGA locus revealed in a parentage testing case.","date":"2015","source":"Forensic science international. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26186693","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40722683","id":"PMC_40722683","title":"Proteomic Profiling Reveals TPR and FGA as Predictive Serum Biomarkers of Relapse to First- and Second-Generation EGFR-TKIs in Advanced Lung Adenocarcinoma.","date":"2025","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/40722683","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20533267","id":"PMC_20533267","title":"[Negative association of FGA gene 128C/G polymorphism with cerebral infarction and its effect on plasma fibrinogen in Hunan Hans].","date":"2010","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20533267","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41512179","id":"PMC_41512179","title":"FGA Serves as a Potential Diagnostic Marker and Therapeutic Target for Elderly Acute Kidney Injury.","date":"2026","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/41512179","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15782779","id":"PMC_15782779","title":"Population studies for STR loci (D3S1358, D5S818, D7S820, D18S51 and FGA) in NWFP and Sindhi populations of Pakistan for forensic use.","date":"2004","source":"Archiwum medycyny sadowej i kryminologii","url":"https://pubmed.ncbi.nlm.nih.gov/15782779","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11591050","id":"PMC_11591050","title":"[Genetic studies in the Cologne administrative district (North Rhine-Westphalia, Germany): DNA-STR systems FGA, TH01, VWA and YNZ22].","date":"2001","source":"Anthropologischer Anzeiger; Bericht uber die biologisch-anthropologische Literatur","url":"https://pubmed.ncbi.nlm.nih.gov/11591050","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10646230","id":"PMC_10646230","title":"DNA-PCR system FGA (FIBRA)--genotype and allele frequencies in a sample of western Germany (Düsseldorf region).","date":"1999","source":"Collegium antropologicum","url":"https://pubmed.ncbi.nlm.nih.gov/10646230","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41233956","id":"PMC_41233956","title":"Congenital hypofibrinogenemia with bleeding risk: mutations in the FGA, FGB, and FGG genes.","date":"2026","source":"Laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41233956","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29070135","id":"PMC_29070135","title":"[Genetic Analysis of A Case of Congenital Dysfibrinogenemia Caused by Arg16His Mutation in Exon 2 of FGA].","date":"2017","source":"Zhongguo shi yan xue ye xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/29070135","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41741162","id":"PMC_41741162","title":"Immunosuppressive Pulse Therapy Alleviates Ocular Surface Damage in Thyroid-Associated Ophthalmopathy by Reversing FGA Deficiency Subsequently Modulating Complement and Coagulation Cascade Signaling to Suppress Orbital Fibroblast Pathology.","date":"2026","source":"Immunological investigations","url":"https://pubmed.ncbi.nlm.nih.gov/41741162","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19065534","id":"PMC_19065534","title":"[Identification of a rare allele of FGA-13].","date":"2008","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19065534","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40394574","id":"PMC_40394574","title":"FGA can be used as a promising therapeutic target in osteoarthritis.","date":"2025","source":"BMC musculoskeletal disorders","url":"https://pubmed.ncbi.nlm.nih.gov/40394574","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24327161","id":"PMC_24327161","title":"[Identification of a rare allele FGA-13 in Guangdong Han population].","date":"2013","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24327161","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12536389","id":"PMC_12536389","title":"[Study of the high polymorphism STR locus-FGA in Chinese population].","date":"1999","source":"Fa yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/12536389","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.11.03.25339246","title":"Characterizing Post-stroke Gait Propulsion Beyond Walking Speed: A Clinically Feasible Approach Using the Functional Gait Assessment","date":"2025-11-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.03.25339246","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.22.25334215","title":"Genomic Divergence Between Matched Primary and Metastatic Tumors Across Cancer Types: A Pan-Cancer Analysis of 5,692 Samples","date":"2025-08-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.22.25334215","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.19.25333982","title":"Multi-Layered Dysregulation of NRCAM in Gliomas: Insights from TCGA Copy Number and Epigenetic Analyses","date":"2025-08-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.19.25333982","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.12.17.628985","title":"A Low-Cost Markerless motion capture system to automate Functional Gait Assessment: Feasibility Study","date":"2024-12-20","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.17.628985","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.09.25323497","title":"Pan-Omics Fusion and Machine Learning Unveil Congenital Tooth Agenesis-Ecto-mesodermal Diseases Link and Biomarker Discovery","date":"2025-03-11","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.09.25323497","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.02.18.638886","title":"Chronic sleep curtailment expediates brain aging by activating the complement and coagulation cascades in mice","date":"2025-02-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.18.638886","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.10.11.24315305","title":"A Pilot Interventional Study on Feasibility and Effectiveness of the CUE1 device in Parkinson’s disease","date":"2024-10-11","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.11.24315305","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.05.15.654000","title":"Differential Proteomic Analysis of DEN-Induced Hepatocellular Carcinoma in Male and Female Balb/c Mice Reveals Novel Gender Specific Markers","date":"2025-05-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.15.654000","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.07.04.24309921","title":"The Great Genotyper: A Graph-Based Method for Population Genotyping of Small and Structural Variants","date":"2024-07-05","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.04.24309921","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.09.19.613013","title":"An Inflammation Centered Perspective to the Mechanisms and Interactions Related to Vascular Cognitive Impairment","date":"2024-09-20","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.19.613013","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10391209","id":"PMC_10391209","title":"Characterization of single-nucleotide polymorphisms in coding regions of human genes.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10391209","citation_count":1381,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14718574","id":"PMC_14718574","title":"The human plasma proteome: a nonredundant list developed by combination of four separate sources.","date":"2004","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/14718574","citation_count":658,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6383194","id":"PMC_6383194","title":"Fibrinogen and fibrin.","date":"1984","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6383194","citation_count":600,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12665801","id":"PMC_12665801","title":"Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.","date":"2003","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/12665801","citation_count":485,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12050338","id":"PMC_12050338","title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.","date":"2002","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12050338","citation_count":451,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26871637","id":"PMC_26871637","title":"Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26871637","citation_count":423,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17643375","id":"PMC_17643375","title":"Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17643375","citation_count":367,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22582013","id":"PMC_22582013","title":"Secreted kinase phosphorylates extracellular proteins that regulate biomineralization.","date":"2012","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/22582013","citation_count":365,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9333233","id":"PMC_9333233","title":"Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9333233","citation_count":360,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16335952","id":"PMC_16335952","title":"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.","date":"2005","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/16335952","citation_count":350,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8100742","id":"PMC_8100742","title":"Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8100742","citation_count":315,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7356959","id":"PMC_7356959","title":"Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences.","date":"1980","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7356959","citation_count":294,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26091039","id":"PMC_26091039","title":"A Single Kinase Generates the Majority of the Secreted Phosphoproteome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26091039","citation_count":270,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15146197","id":"PMC_15146197","title":"Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15146197","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16581250","id":"PMC_16581250","title":"p130Cas: a versatile scaffold in signaling networks.","date":"2006","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16581250","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19296670","id":"PMC_19296670","title":"Crystal structure of human fibrinogen.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19296670","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15174051","id":"PMC_15174051","title":"An investigation into the human serum \"interactome\".","date":"2004","source":"Electrophoresis","url":"https://pubmed.ncbi.nlm.nih.gov/15174051","citation_count":247,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"5645286","id":"PMC_5645286","title":"Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen?","date":"1968","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/5645286","citation_count":224,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10467729","id":"PMC_10467729","title":"Fibrinogen.","date":"1999","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10467729","citation_count":223,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43478,"output_tokens":4630,"usd":0.099942},"stage2":{"model":"claude-opus-4-6","input_tokens":8153,"output_tokens":3224,"usd":0.182048},"total_usd":0.629048,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":54097,"output_tokens":6785,"usd":0.132033},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":10540,"output_tokens":3626,"usd":0.215025}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Homozygous deletions of approximately 11 kb of the FGA gene (fibrinogen alpha-chain) cause congenital afibrinogenemia by eliminating the capacity to synthesize functional fibrinogen, establishing FGA as essential for fibrinogen production.\",\n      \"method\": \"Southern blotting, haplotype analysis, genetic deletion mapping\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct deletion mapping in multiple affected individuals, replicated across independent ancestral chromosomes\",\n      \"pmids\": [\"9916133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The ~11 kb FGA deletion responsible for congenital afibrinogenemia is mediated by non-homologous (illegitimate) recombination at a 7 bp direct repeat (AACTTTT) present in FGA intron 1 and the FGA-FGB intergenic sequence, with flanking inverted repeats contributing to secondary structure formation.\",\n      \"method\": \"Nucleotide sequence analysis of deletion junctions, comparison with normal sequences, haplotype analysis\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — sequence-level characterization of three independent deletion junctions with mechanistic explanation\",\n      \"pmids\": [\"10602365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The common afibrinogenemia mutation FGA IVS4+1 G→T activates multiple cryptic donor splice sites in exon 4 and intron 4; the predominant cryptic site (used in 85% of transcripts) is 4 bp downstream of the normal site, causing a 4-bp insertion-frameshift leading to premature alpha-chain truncation and afibrinogenemia.\",\n      \"method\": \"Transfection of mutant and normal plasmid constructs in COS-7 cells, RT-PCR analysis of aberrant mRNAs\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional splicing assay in transfected cells with direct mRNA analysis, confirmed null mutation\",\n      \"pmids\": [\"11238133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The outcome of FGA donor splice mutations reflects the order of intron removal: FGA intron 3 is preferentially spliced first (followed by intron 2, intron 4, intron 1), so the IVS3 mutation causes exon 3 skipping (99% of transcripts), while later-spliced intron mutations lead to intron inclusion or cryptic splice-site use.\",\n      \"method\": \"Transfected cell splicing assay (COS-7), RT-PCR, analysis of IVS3delGTAA and IVS1+3A>G mutations\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional reconstitution of splicing mechanism with multiple mutations, mechanistic model validated\",\n      \"pmids\": [\"12406899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A nonsense mutation in FGA exon 5 (c.718C>T; p.Q240X) encodes a truncated Aα-chain that can be detected in cell media of transfected COS-7 cells but is less efficiently secreted compared to wild-type, demonstrating that premature truncation impairs fibrinogen secretion.\",\n      \"method\": \"Expression of mutant Aα-chain cDNA combined with wild-type Bβ and γ chains in COS-7 cells, comparison of secretion levels\",\n      \"journal\": \"Blood coagulation & fibrinolysis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with wild-type and mutant chains, quantitative secretion comparison\",\n      \"pmids\": [\"20051841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A deletion variant FGA c.169_180+2 del (fibrinogen Shanghai) causes exon 2 skipping, producing a truncated Aα chain with 42 N-terminal amino acid deletion; this impairs fibrinopeptide A release, prolongs fibrin polymerization lag time, slows maximum polymerization slope, and alters clot structure (thicker fibres, looser network) without affecting fibrinogen synthesis, assembly, or secretion.\",\n      \"method\": \"FGA minigene transfection assay, turbidity-based fibrin polymerization and clot lysis assays, reversed-phase HPLC for fibrinopeptide release, scanning electron microscopy of clot ultrastructure\",\n      \"journal\": \"Journal of clinical pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal functional assays (splicing, polymerization, fibrinopeptide release, ultrastructure) in a single study\",\n      \"pmids\": [\"27555433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FGA minigene analysis showed that the 1238 bp FGA deletion generates two aberrant mRNAs both causing frameshift and premature termination, while a FGA c.54+3A>C substitution generates one aberrant mRNA with frameshift/premature stop and another using a cryptic 5' splice site that deletes six signal-peptide amino acids; both mechanisms lead to lack of mature Aα-chain and impaired fibrinogen assembly/secretion.\",\n      \"method\": \"Minigene cloning and transfection in CHO cells, RT-PCR and sequencing of aberrant cDNAs\",\n      \"journal\": \"International journal of hematology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — minigene functional assay with direct cDNA sequencing demonstrating molecular mechanism\",\n      \"pmids\": [\"22639050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A conserved regulatory element (PFE2) located between FGA and FGG genes functions as a liver-specific enhancer, stimulating FGA promoter-driven gene expression in hepatoma cells regardless of orientation, and drives reporter gene expression in transgenic zebrafish larval livers in vivo.\",\n      \"method\": \"Luciferase reporter gene assay in hepatoma cells, transgenic zebrafish EGFP reporter assay, ChIP-seq data integration\",\n      \"journal\": \"Thrombosis and haemostasis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro promoter assay plus in vivo transgenic zebrafish validation, bi-directional orientation tested\",\n      \"pmids\": [\"22836734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"siRNA-mediated 50% knockdown of FGA mRNA in HepG2 cells reduced secreted fibrinogen to 78% of control, whereas equivalent knockdown of FGB or FGG reduced fibrinogen to 49% or 57%, respectively; FGG mRNA levels are rate-limiting for fibrinogen expression in normal liver and HepG2 cells, and heterozygous FGA abnormality does not limit fibrinogen output.\",\n      \"method\": \"siRNA knockdown of FGA, FGB, or FGG in HepG2 cells, real-time quantitative RT-PCR for mRNA levels, measurement of secreted fibrinogen in media\",\n      \"journal\": \"Thrombosis research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic siRNA knockdown of each chain gene with functional secretion readout, three-gene comparison\",\n      \"pmids\": [\"23414568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Lentiviral transduction of FGA into hepatocytes homozygous for a large FGA deletion restored Aα-chain protein expression and enabled secretion of a fully functional fibrinogen hexamer in vitro, demonstrating that FGA is the sole limiting component for functional fibrinogen assembly in these cells.\",\n      \"method\": \"Lentiviral vector transduction of patient-derived FGA-deficient hepatocytes, functional fibrinogen assay in transduced cell media\",\n      \"journal\": \"Journal of thrombosis and haemostasis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — gene complementation with functional fibrinogen secretion confirmed in patient-derived cells\",\n      \"pmids\": [\"25163824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Targeted frameshift mutations in the zebrafish fga gene (via zinc finger nucleases) result in undetectable fibrinogen in plasma and cause spontaneous hemorrhaging and reduced survival, confirming that FGA is essential for fibrinogen production and hemostasis in vivo.\",\n      \"method\": \"Zinc finger nuclease-mediated targeted mutagenesis in zebrafish, anti-zebrafish fibrinogen antibody panel, survival analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function model with multiple distinct frameshift alleles, direct fibrinogen protein measurement, defined bleeding phenotype\",\n      \"pmids\": [\"24553182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Familial FGA mutations associated with renal amyloidosis (E540V and R554L) increase in vitro amyloidogenicity of the FGA(496–581) C-terminal fragment: E540V causes amyloid-like fibril formation (observed by AFM) while R554L produces β-sheet-rich globular aggregates with amyloid-like properties, whereas wild-type FGA(496–581) remains monomeric at physiological pH.\",\n      \"method\": \"In vitro aggregation assay with recombinant FGA fragment, atomic force microscopy (AFM) imaging\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutant vs. wild-type fragment, single lab, AFM structural characterization\",\n      \"pmids\": [\"27126074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A novel FGA mutation (g.3057 C>T; p.Arg104Cys) impairs fibrinogen secretion: reverse phase electrospray TOF-MS showed the variant Aα chain constitutes only ~25% of total plasma fibrinogen, establishing that Aα Arg104 is critical for efficient secretion of the fibrinogen hexamer.\",\n      \"method\": \"DNA sequencing, reverse phase-electrospray TOF-MS for plasma protein quantification, turbidity-based fibrin polymerization, confocal microscopy of clot structure\",\n      \"journal\": \"BMC hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — mass spectrometry directly quantified mutant chain underrepresentation in plasma, single lab study\",\n      \"pmids\": [\"29299315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Mice carrying an Fga truncation at residue 271 (Fga270 mice) are hypofibrinogenemic (~10% plasma fibrinogen) due to 90% reduction in hepatic Fga mRNA caused by nonsense-mediated mRNA decay of the mutant transcript; platelet fibrinogen is ~30% of wild-type with compensatory fibronectin increase; these mice have preserved hemostasis but are completely protected from venous thrombosis in an inferior vena cava stasis model, and support fibrinogen-mediated bacterial clearance comparable to wild-type.\",\n      \"method\": \"Mouse knock-in model, plasma fibrinogen quantification, hepatic mRNA quantification, platelet aggregation assay, tail bleeding, laser-induced saphenous vein injury model, IVC stasis thrombosis model, S. aureus peritonitis model, siRNA fibrinogen reduction experiment\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal in vivo models, mRNA mechanism identified (NMD), siRNA validation, replicated functional findings across assays\",\n      \"pmids\": [\"34905618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FGA knockdown in endometrial stromal cells reduces secretion of VEGFA, PDGF, FGF-B, MMP-2, and MMP-9, and conditioned medium from FGA-knockdown cells inhibits HUVEC tube formation and migration; mechanistically, FGA promotes angiogenesis via a VEGFA-VEGFR2-FAK signaling axis.\",\n      \"method\": \"siRNA knockdown, conditioned medium experiments, tube formation assay, wound healing/transwell assay, western blotting for VEGFR2/FAK pathway, matrigel plug assay in vivo, immunofluorescence for F-actin/VE-cadherin\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined signaling pathway and in vivo validation, single lab\",\n      \"pmids\": [\"35498401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FGA overexpression in gastric cancer cells inhibits ITGA5 (integrin-α5) expression (confirmed by luciferase and ChIP assays showing FGA transcriptionally suppresses ITGA5), suppresses the FAK/ERK pathway, inhibits cell proliferation, motility, and EMT, and induces autophagy; FGA knockout activates PI3K/AKT pathway; in vivo, FGA overexpression restricts tumor growth in nude mice.\",\n      \"method\": \"Luciferase assay, ChIP assay, siRNA/overexpression constructs, CCK-8/colony formation, wound healing/transwell, double-label RFP-GFP-LC3 immunofluorescence for autophagy, western blotting, xenograft mouse model\",\n      \"journal\": \"Tissue & cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays with defined pathway and transcriptional mechanism, single lab\",\n      \"pmids\": [\"35257941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FGA overexpression in hepatocellular carcinoma cells increases E-cadherin and decreases N-cadherin and slug expression (suppressing EMT), inhibits cell migration and invasion; FGA knockout activates the PI3K/AKT pathway; in a mouse metastasis model, FGA overexpression restricts tumor cell spread.\",\n      \"method\": \"FGA knockout and overexpression cell models, transwell migration/invasion assay, wound healing assay, western blotting for EMT markers and PI3K/AKT pathway, mouse metastasis model\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with defined pathway and in vivo validation, single lab\",\n      \"pmids\": [\"39227068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FGA expression in granulosa cells is regulated by histone acetylation: HDAC2 knockdown reduces chromatin accessibility and H3K9ac enrichment at the FGA promoter (−1350/−1454 bp region), decreasing FGA protein levels; FGA promotes granulosa cell proliferation and cell cycle progression (upregulating PCNA and CCNE1) and inhibits apoptosis by suppressing Caspase3 and Caspase9; in vivo, FGA inhibits GC apoptosis and increases corpora lutea number.\",\n      \"method\": \"HDAC1/2/3 siRNA knockdown, ATAC-seq for chromatin accessibility, ChIP for H3K9ac at FGA promoter, CCK-8/colony formation for proliferation, flow cytometry for apoptosis, western blotting, in vivo mouse experiments\",\n      \"journal\": \"Biological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrates direct H3K9ac regulation at FGA promoter; multiple functional assays in vitro and in vivo; single lab\",\n      \"pmids\": [\"40605115\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FGA encodes the fibrinogen Aα chain, which is synthesized predominantly in hepatocytes under transcriptional control of a liver-specific enhancer (PFE2) and histone acetylation (H3K9ac at the promoter via HDAC2); the Aα chain assembles with Bβ and γ chains into the hexameric fibrinogen molecule (with FGG mRNA being rate-limiting), and is secreted into plasma where it is cleaved by thrombin (releasing fibrinopeptide A) to initiate fibrin polymerization and clot formation; loss-of-function mutations cause afibrinogenemia or hypofibrinogenemia through mechanisms including genomic deletion, nonsense-mediated mRNA decay, aberrant splicing, or impaired secretion of the truncated chain, while missense mutations in the αC-domain can cause dysfibrinogenemia with altered polymerization kinetics or increased amyloidogenicity; beyond coagulation, FGA also regulates angiogenesis via a VEGFA-VEGFR2-FAK signaling axis, suppresses tumor cell invasion and EMT partly through transcriptional repression of ITGA5 and inhibition of FAK/ERK and PI3K/AKT pathways, and promotes follicular granulosa cell survival by suppressing caspase-mediated apoptosis.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify papers, then extract discoveries from KEEP papers only.\n\n**Classification notes:**\n- Papers 35 (woodlice \"fga\" = female genital aperture in Armadillidium), 54 (18F-FGA = fluoro glucaric acid PET tracer), 82/85/88 (FGA = Functional Gait Assessment), 83/84 (FGA = Fraction Genome Altered) → EXCLUDE (symbol collision/alias collision)\n- Papers 1-3 of gene2pubmed set (large proteomics panels), forensic STR papers (6,13,18,23,31,32,37,42,44,49,57,64,65,66,68,72,73,74,78,80,81) → EXCLUDE (no mechanistic findings about FGA protein)\n- Papers about biomarker associations only (expression/survival) without mechanism → EXCLUDE\n- Papers with actual mechanistic findings about FGA protein (fibrinogen alpha chain) → KEEP\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Homozygous deletion of approximately 11 kb of the fibrinogen alpha-chain gene (FGA) causes complete absence of fibrinogen (congenital afibrinogenemia), establishing that FGA is required for fibrinogen synthesis and secretion in humans, analogous to findings in mice.\",\n      \"method\": \"Southern blotting, PCR, haplotype analysis of affected pedigree members\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct genetic loss-of-function with defined molecular and clinical phenotype, replicated across multiple independent chromosomes\",\n      \"pmids\": [\"9916133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The recurrent 11 kb FGA deletion arises from non-homologous (illegitimate) recombination mediated by a 7 bp direct repeat (AACTTTT) located in FGA intron 1 and the FGA-FGB intergenic sequence, together with flanking inverted repeats that can form secondary structures.\",\n      \"method\": \"Nucleotide sequence analysis of deletion junctions, comparison with normal sequences, flanking polymorphic marker haplotyping\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct sequencing of all three independent deletion junctions with mechanistic interpretation\",\n      \"pmids\": [\"10602365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The most common congenital afibrinogenemia mutation, FGA IVS4+1G>T, causes aberrant mRNA splicing by activating multiple cryptic donor splice sites in exon 4 and intron 4; the predominant cryptic site (4 bp downstream) is used in 85% of transcripts, causing a frameshift and premature Aα-chain truncation (null allele).\",\n      \"method\": \"Transfection of normal and mutant minigene constructs into COS-7 cells, RT-PCR analysis of aberrant mRNA products\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro minigene splicing assay with molecular characterization of multiple aberrant transcripts\",\n      \"pmids\": [\"11238133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The outcome of FGA donor splice-site mutations reflects the order of intron removal: intron 3 is spliced first, followed by intron 2, intron 4, and intron 1. Mutations in rapidly spliced introns (e.g., IVS3) predominantly cause exon skipping, while mutations in later-spliced introns (e.g., IVS4) lead to cryptic splice-site utilization or intron inclusion.\",\n      \"method\": \"Minigene transfection in COS-7 cells, RT-PCR analysis of splicing outcomes for IVS3delGTAA and IVS1+3A>G mutations\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro minigene assay with multiple mutations revealing mechanistic rule for splicing order\",\n      \"pmids\": [\"12406899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Crystal structure of fibrinogen fragment D (from human fibrinogen) determined at 2.9 Å resolution, revealing a three-chained structure with a coiled-coil region and two homologous globular entities oriented ~130° to each other; the double-D fragment from fibrin, solved with a Gly-Pro-Arg-Pro-amide peptide ligand, defined the donor polymerization site.\",\n      \"method\": \"X-ray crystallography at 2.9 Å; molecular replacement for double-D\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional ligand (polymerization site peptide), foundational structural paper\",\n      \"pmids\": [\"9333233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of human fibrinogen determined at ~3.3 Å resolution, revealing the full hexameric (AαBβγ)₂ arrangement, coiled-coil regions with variable twist, an antiparallel β-chain interface, and prominent carbohydrate groups on β chains; αC domains were not resolvable.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct crystal structure of full-length human fibrinogen\",\n      \"pmids\": [\"19296670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1980,\n      \"finding\": \"Synthetic Gly-Pro-Arg peptides bind to fibrinogen and inhibit fibrin polymerization, defining the fibrin polymerization ('knob A') site on the Aα chain and establishing the structural requirements for donor-acceptor interactions in fibrin assembly.\",\n      \"method\": \"Synthetic peptide binding assays, fibrin polymerization inhibition, species-difference analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with defined structural requirements and multiple binding-site quantification\",\n      \"pmids\": [\"7356959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Fibrinogen mediates leukocyte adhesion to vascular endothelium through a mechanism requiring ICAM-1 on endothelial cells; fibrinogen bridges leukocytes and endothelium by binding complementary receptors on both cell types, with ICAM-1 identified as a novel hematopoietic fibrinogen receptor by affinity chromatography and direct binding to recombinant protein.\",\n      \"method\": \"Affinity chromatography purification, genetically engineered ICAM-1 transfectants, direct binding assays, adhesion assays with blocking antibodies\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including receptor identification, transfectant validation, and direct binding to recombinant protein\",\n      \"pmids\": [\"8100742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Fibrinogen alpha-chain (FGA) is a secreted glycoprotein phosphorylated at S-x-E motifs in the secretory pathway; Fam20C (Golgi casein kinase) phosphorylates FGA as part of the broader extracellular phosphoproteome.\",\n      \"method\": \"Mass spectrometry identification of phosphorylation sites; CRISPR/Cas9 Fam20C knockout followed by secreted phosphoproteome analysis\",\n      \"journal\": \"Science / Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — FGA identified as Fam20C substrate in large-scale phosphoproteomics with genetic validation, but FGA-specific functional consequences not individually characterized\",\n      \"pmids\": [\"22582013\", \"26091039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Misdiagnosis study established that fibrinogen Aα-chain (FGA) mutations are the most common cause of hereditary systemic amyloidosis misdiagnosed as AL amyloidosis, confirming that mutant FGA protein deposits as amyloid primarily in kidneys.\",\n      \"method\": \"Genetic screening for amyloidogenic mutations in 350 patients; histological and laboratory confirmation of hereditary amyloidosis\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic genetic and pathological characterization of 350 patients, multiple confirmatory investigations per patient\",\n      \"pmids\": [\"12050338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Two familial FGA mutations associated with renal amyloidosis (E540V and R554L in the C-terminal αC-region fragment FGA(496-581)) enhance amyloidogenicity: E540V causes amyloid-like fibril formation and R554L causes globular β-sheet-rich aggregates at physiological pH, whereas wild-type FGA(496-581) remains monomeric.\",\n      \"method\": \"In vitro aggregation assays of recombinant FGA(496-581) fragments; atomic force microscopy (AFM); circular dichroism for β-sheet content\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with AFM imaging; single lab, two mutations tested\",\n      \"pmids\": [\"27126074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A novel nonsense mutation in FGA exon 5 (c.718C>T, p.Q240X) causes afibrinogenemia; expression of the mutant Aα-chain cDNA with wild-type Bβ and γ chains in COS-7 cells showed the truncated chain is produced but less efficiently secreted than wild-type, establishing that the Aα Q240X truncation impairs fibrinogen secretion rather than synthesis.\",\n      \"method\": \"COS-7 cell co-transfection of mutant and wild-type fibrinogen chain cDNAs; immunodetection in cell media\",\n      \"journal\": \"Blood coagulation & fibrinolysis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional expression assay directly testing secretion of mutant Aα chain\",\n      \"pmids\": [\"20051841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A novel regulatory element (PFE2) located between FGA and FGG genes functions as a potent hepatocyte enhancer in both orientations; PFE2 enhances FGA promoter-driven gene expression in hepatoma cells and drives EGFP expression in transgenic zebrafish larval livers, identifying a cis-regulatory element controlling FGA transcription.\",\n      \"method\": \"Luciferase reporter assays in hepatoma cells; transgenic zebrafish GFP reporter assay; ChIP-seq data integration\",\n      \"journal\": \"Thrombosis and haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo functional enhancer validation with multiple orientations tested\",\n      \"pmids\": [\"22836734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"siRNA-mediated knockdown of FGA mRNA by ~50% in HepG2 cells reduces secreted fibrinogen to only 78% of control, whereas equivalent knockdown of FGB or FGG reduces fibrinogen to 49% or 57%, demonstrating that FGA mRNA is present in excess relative to FGB and FGG, and that FGG mRNA is the rate-limiting component for fibrinogen expression in normal liver.\",\n      \"method\": \"siRNA knockdown of individual fibrinogen chains in HepG2 cells; quantitative RT-PCR for mRNA levels; ELISA for secreted fibrinogen\",\n      \"journal\": \"Thrombosis research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic siRNA knockdown of each chain with quantitative output, revealing stoichiometric regulation\",\n      \"pmids\": [\"23414568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Zinc finger nuclease-mediated frameshift mutations in zebrafish fga produce homozygous fish with undetectable plasma fibrinogen, hemorrhaging, and reduced survival, validating fga as the causative locus for afibrinogenemia and establishing the first transmissible zebrafish model of this human bleeding disorder.\",\n      \"method\": \"Zinc finger nuclease gene targeting; anti-fibrinogen antibody detection in plasma; hemorrhage phenotype scoring; survival analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic knockout model with multiple independent alleles and defined molecular and phenotypic readouts\",\n      \"pmids\": [\"24553182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Lentiviral transduction of the human FGA cDNA into hepatocytes from an afibrinogenemia patient (homozygous FGA deletion) restores Aα-chain expression and secretion of fully functional fibrinogen hexamer in vitro, demonstrating that gene delivery of FGA alone is sufficient for functional fibrinogen assembly and secretion.\",\n      \"method\": \"Lentiviral vector transduction of patient-derived hepatocytes; functional fibrinogen assays in conditioned media\",\n      \"journal\": \"Journal of thrombosis and haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional rescue experiment in patient-derived cells\",\n      \"pmids\": [\"25163824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The FGA variant c.169_180+2 del (fibrinogen Shanghai) causes exon 2 skipping, producing a shortened Aα chain with 42 N-terminal amino acid truncation; patient fibrinogen shows impaired fibrinopeptide A release by thrombin, prolonged polymerization lag time, slower maximum slope, reduced final turbidity, and thicker fibres with looser clot network by scanning electron microscopy, without affecting fibrinogen synthesis or secretion.\",\n      \"method\": \"FGA minigene transfection splicing assay; turbidimetric fibrin polymerization and lysis assays; reversed-phase HPLC for fibrinopeptide release; scanning electron microscopy of fibrin clots\",\n      \"journal\": \"Journal of clinical pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biochemical and structural methods characterizing functional consequences of the Aα N-terminal truncation\",\n      \"pmids\": [\"27555433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The FGA mutation p.Arg104Cys (g.3057C>T) causes hypodysfibrinogenemia; mass spectrometry (TOF-MS) showed the variant Aα chain represents only ~25% of total circulating Aα chain, indicating impaired secretion of the mutant chain. Plasmin degradation and fibrinogen-albumin complex formation were normal, while clot structure was nearly normal by confocal microscopy.\",\n      \"method\": \"Reverse phase-electrospray TOF-MS for chain quantification; turbidimetric polymerization; immunoblotting for albumin complexes; confocal microscopy of clot structure; SDS-PAGE of plasmin degradation products\",\n      \"journal\": \"BMC hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — direct quantification of mutant chain secretion by MS with multiple functional assays\",\n      \"pmids\": [\"29299315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Mice carrying the Fga270 premature termination codon (at residue 271, within the αC-region) are hypofibrinogenemic (~10% plasma fibrinogen) due to nonsense-mediated decay of mutant Fga mRNA (90% reduction in hepatic mRNA); despite low plasma fibrinogen, these mice have preserved hemostasis in tail bleeding and laser-injury models, normal initial platelet aggregation, and are fully protected from venous thrombosis (IVC stasis model). Platelet fibrinogen is ~30% of wild-type with compensatory fibronectin increase, revealing that αC-region truncation selectively reduces plasma but partially preserves platelet fibrinogen.\",\n      \"method\": \"Targeted mouse knock-in; plasma fibrinogen ELISA; hepatic mRNA quantification; tail bleeding assay; laser-induced saphenous vein injury; IVC stasis thrombosis model; platelet aggregometry; platelet fibrinogen and fibronectin quantification; S. aureus peritonitis survival model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vivo and in vitro orthogonal methods across hemostasis, thrombosis, and infection models with mechanistic explanation (NMD, platelet compensation)\",\n      \"pmids\": [\"34905618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FGA (fibrinogen alpha chain) knockdown in endometrial stromal cells reduces VEGFA, PDGF, FGF-B, MMP-2, and MMP-9 expression, and the conditioned medium from FGA-knockdown cells inhibits HUVEC tube formation, migration, VE-cadherin expression, microfilament formation, and suppresses VEGFR2 and FAK signaling, establishing that FGA promotes angiogenesis via a VEGFA-VEGFR2-FAK signaling axis.\",\n      \"method\": \"FGA siRNA knockdown in endometrial stromal cells; conditioned medium transfer to HUVECs; tube formation assay; wound/transwell migration assays; matrigel plug assay in vivo; Western blotting for VEGFR2/FAK phosphorylation; immunofluorescence for F-actin/VE-cadherin\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — conditioned medium approach with multiple functional readouts and pathway validation, single lab\",\n      \"pmids\": [\"35498401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FGA overexpression in gastric cancer cells suppresses ITGA5 (Integrin-α5) transcription (confirmed by luciferase and ChIP assays), inhibits FAK/ERK pathway activity, suppresses migration, invasion, EMT, and induces autophagy; FGA knockout activates FAK/ERK and promotes tumor growth in nude mouse xenografts.\",\n      \"method\": \"FGA overexpression/knockout cell models; transwell and wound healing assays; luciferase reporter and ChIP assays for ITGA5 transcription; Western blotting for FAK/ERK; RFP-GFP-LC3 autophagy assay; in vivo xenograft\",\n      \"journal\": \"Tissue & cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase + ChIP establish transcriptional mechanism; FAK/ERK pathway placement by loss-of-function with multiple readouts\",\n      \"pmids\": [\"35257941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FGA overexpression in hepatocellular carcinoma cells increases E-cadherin and decreases N-cadherin and Slug (EMT markers), inhibits cell migration and invasion; FGA knockout activates the PI3K/AKT pathway, and FGA overexpression restricts tumor spread in a mouse metastasis model.\",\n      \"method\": \"FGA overexpression and knockout cell models; Transwell migration/invasion assays; wound healing assay; Western blotting for EMT markers and PI3K/AKT; in vivo mouse metastasis model\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — genetic loss- and gain-of-function with pathway placement (PI3K/AKT) and in vivo validation, single lab\",\n      \"pmids\": [\"39227068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Computational modeling and in vitro aggregation experiments show that vitamin C and vitamin D3 interact with amyloidogenic sites of E524K and E526K FGA C-terminal mutants, reducing amyloid fibril formation; Congo red assays, aggregation index measurements, and AFM imaging confirm smaller aggregates in the presence of vitamin D3.\",\n      \"method\": \"Molecular docking; MD simulation-derived binding free energy; Congo red absorbance; aggregation index; AFM imaging of aggregates\",\n      \"journal\": \"The Journal of steroid biochemistry and molecular biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3–4 — primarily computational with limited in vitro confirmation; no structural or mechanistic validation beyond aggregate size\",\n      \"pmids\": [\"36907427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FGA expression in granulosa cells is regulated by histone acetylation: HDAC2 knockdown reduces chromatin accessibility and H3K9ac enrichment at the FGA promoter region (-1350/-1454 bp), suppressing FGA transcription. FGA promotes granulosa cell proliferation and cell cycle progression (upregulating PCNA and CCNE1) and inhibits apoptosis (suppressing Caspase3 and Caspase9) both in vitro and in vivo, advancing pubertal initiation in mice.\",\n      \"method\": \"HDAC1/2/3 siRNA knockdown; ATAC-seq for chromatin accessibility; ChIP for H3K9ac at FGA promoter; FGA knockdown/overexpression in granulosa cells; flow cytometry for cell cycle/apoptosis; Western blotting for PCNA, CCNE1, Caspase3/9; in vivo mouse model for corpora lutea and estradiol\",\n      \"journal\": \"Biological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + ATAC-seq establish epigenetic mechanism; multiple functional readouts in vitro and in vivo, single lab\",\n      \"pmids\": [\"40605115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A minigene corresponding to the FGAΔ1238 deletion generates two aberrant mRNAs with frameshifts causing premature termination; the FGA c.54+3A>C substitution activates a cryptic 5' splice site in exon 1, producing one transcript with a frameshift and another deleting six amino acids from the signal peptide, both predicted to impair Aα-chain assembly/secretion.\",\n      \"method\": \"Minigene cloning and transfection into CHO cells; RT-PCR and sequencing of aberrant mRNAs\",\n      \"journal\": \"International journal of hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro minigene splicing assay with molecular characterization of aberrant transcripts\",\n      \"pmids\": [\"22639050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A mutation of the FGA translation initiation codon (c.1A>T, M1L) causes congenital afibrinogenemia, establishing that the canonical ATG start codon is essential for Aα-chain translation and hence fibrinogen synthesis.\",\n      \"method\": \"PCR amplification and Sanger sequencing of all FGA exons; compound heterozygosity with FGA c.385C>T (R129X) in a patient with afibrinogenemia\",\n      \"journal\": \"Blood coagulation & fibrinolysis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic identification of start codon mutation; functional null established by complete fibrinogen absence\",\n      \"pmids\": [\"22732251\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FGA encodes the fibrinogen Aα chain, which is synthesized in hepatocytes under transcriptional control of a liver enhancer (PFE2) and HDAC2-regulated H3K9ac at its promoter; FGA mRNA is present in stoichiometric excess over FGB and FGG (with FGG being rate-limiting), and the Aα chain assembles with Bβ and γ chains into the (AαBβγ)₂ hexamer whose crystal structure (2.9–3.3 Å) reveals a coiled-coil scaffold with globular D-domains harboring the 'knob A' (Gly-Pro-Arg) polymerization site; upon thrombin cleavage of fibrinopeptide A, fibrin polymerization proceeds through knob-hole interactions whose structural requirements are defined by synthetic peptide inhibition studies; the αC-region (residues ~271 onward) is required for normal plasma fibrinogen levels (its truncation triggers nonsense-mediated mRNA decay and reduces circulating fibrinogen ~90%) but is dispensable for hemostasis and bacterial clearance at ~10% fibrinogen; fibrinogen bridges leukocytes to endothelium via ICAM-1; familial αC-region mutations (E540V, R554L) increase amyloidogenicity and cause renal amyloid deposition; in non-hepatic contexts FGA suppresses cancer cell invasion by transcriptionally repressing ITGA5/FAK/ERK and PI3K/AKT signaling, and promotes angiogenesis in endometrial stromal cells via a VEGFA-VEGFR2-FAK axis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FGA encodes the fibrinogen Aα chain, an essential subunit of the hexameric fibrinogen molecule that is assembled with Bβ and γ chains in hepatocytes and secreted into plasma, where thrombin cleavage releases fibrinopeptide A to initiate fibrin polymerization and hemostasis [PMID:9916133, PMID:24553182, PMID:27555433]. FGA transcription in liver is driven by a conserved intergenic enhancer (PFE2) and regulated by histone acetylation (H3K9ac) at its promoter, with FGG mRNA being rate-limiting for overall fibrinogen output [PMID:22836734, PMID:23414568, PMID:40605115]. Loss-of-function mutations cause congenital afibrinogenemia or hypofibrinogenemia through genomic deletion, aberrant splicing, nonsense-mediated mRNA decay, or impaired secretion of truncated Aα chains, while C-terminal missense variants increase amyloidogenicity of the Aα fragment, linking FGA to hereditary renal amyloidosis [PMID:10602365, PMID:11238133, PMID:20051841, PMID:34905618, PMID:27126074]. Beyond coagulation, FGA promotes angiogenesis via a VEGFA–VEGFR2–FAK axis, suppresses epithelial–mesenchymal transition and tumor invasion through transcriptional repression of ITGA5 and inhibition of PI3K/AKT signaling, and supports granulosa cell survival by suppressing caspase-mediated apoptosis [PMID:35498401, PMID:35257941, PMID:39227068, PMID:40605115].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that FGA is indispensable for fibrinogen production: homozygous ~11 kb genomic deletions of FGA were identified as the cause of congenital afibrinogenemia, proving the gene is essential for fibrinogen biosynthesis.\",\n      \"evidence\": \"Southern blotting, haplotype analysis, and deletion junction sequencing in affected families\",\n      \"pmids\": [\"9916133\", \"10602365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether other FGA mutation classes (missense, splice) can produce quantitative deficiency was not yet tested\",\n        \"No animal model existed to confirm in vivo essentiality\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Revealing how FGA splice-site mutations cause afibrinogenemia: functional splicing assays showed that splice-donor mutations activate cryptic splice sites or cause exon skipping depending on the order of intron removal, with each aberrant mRNA leading to premature termination and loss of functional Aα chain.\",\n      \"evidence\": \"Minigene/plasmid transfection in COS-7 cells with RT-PCR analysis of multiple donor-site mutations (IVS4+1 G→T, IVS3delGTAA, IVS1+3A>C)\",\n      \"pmids\": [\"11238133\", \"12406899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether aberrant mRNAs are degraded by NMD in vivo was not directly tested\",\n        \"No endogenous hepatocyte model was used\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defining the transcriptional control of FGA: a conserved intergenic element (PFE2) was shown to function as a liver-specific enhancer for the FGA promoter, active in both orientations in hepatoma cells and in vivo in zebrafish liver.\",\n      \"evidence\": \"Luciferase reporter assays in hepatoma cells and transgenic zebrafish EGFP reporter with ChIP-seq data integration\",\n      \"pmids\": [\"22836734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which transcription factors bind PFE2 to activate FGA was not identified\",\n        \"Whether PFE2 deletion affects fibrinogen levels in vivo was not tested\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating how FGA mutations cause dysfibrinogenemia versus afibrinogenemia: an exon 2 deletion variant (fibrinogen Shanghai) impaired fibrinopeptide A release and fibrin polymerization kinetics without affecting fibrinogen secretion, while larger deletions and splice variants abolished Aα-chain expression entirely.\",\n      \"evidence\": \"Minigene transfection, turbidity-based polymerization, HPLC for fibrinopeptide release, scanning electron microscopy of clot ultrastructure\",\n      \"pmids\": [\"27555433\", \"22639050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The structural basis by which the 42-aa deletion alters thrombin cleavage was not resolved\",\n        \"Effects on fibrinolysis resistance in vivo were not examined\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Establishing the quantitative hierarchy of fibrinogen chain gene contributions: siRNA knockdown showed FGG mRNA is rate-limiting for fibrinogen secretion, while 50% reduction of FGA mRNA had only modest impact, explaining why heterozygous FGA carriers maintain near-normal fibrinogen levels.\",\n      \"evidence\": \"siRNA knockdown of FGA, FGB, or FGG in HepG2 cells with quantitative secreted fibrinogen measurement\",\n      \"pmids\": [\"23414568\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether this hierarchy holds under inflammatory upregulation (acute-phase response) was not tested\",\n        \"Post-translational assembly bottlenecks were not distinguished from mRNA-level effects\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Confirming FGA in vivo essentiality and demonstrating gene rescue: zebrafish fga frameshift mutants had undetectable fibrinogen and spontaneous bleeding, while lentiviral FGA transduction into patient-derived FGA-null hepatocytes restored functional fibrinogen secretion.\",\n      \"evidence\": \"Zinc finger nuclease mutagenesis in zebrafish; lentiviral transduction of patient hepatocytes with fibrinogen functional assay\",\n      \"pmids\": [\"24553182\", \"25163824\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Sustained in vivo gene therapy correction was not demonstrated\",\n        \"Whether zebrafish phenotype fully models mammalian afibrinogenemia complications was not assessed\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linking FGA C-terminal mutations to amyloidogenicity: recombinant FGA(496–581) fragments carrying renal amyloidosis mutations (E540V, R554L) formed amyloid-like fibrils or β-sheet-rich aggregates in vitro, whereas wild-type fragment remained monomeric.\",\n      \"evidence\": \"In vitro aggregation assay with recombinant protein and atomic force microscopy imaging\",\n      \"pmids\": [\"27126074\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the Aα C-terminal fragment is generated in vivo by specific proteolysis was not shown\",\n        \"No cell-based or animal model of FGA-amyloidosis was used\",\n        \"Seeding or cross-seeding behavior of these aggregates was not tested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolving the threshold of fibrinogen needed for hemostasis versus thrombosis: Fga270 knock-in mice with ~10% plasma fibrinogen (due to NMD of mutant mRNA) maintained hemostasis and bacterial clearance but were completely protected from venous thrombosis.\",\n      \"evidence\": \"Mouse knock-in model with plasma fibrinogen quantification, tail bleeding, laser-induced vein injury, IVC stasis model, S. aureus peritonitis model\",\n      \"pmids\": [\"34905618\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether partial fibrinogen reduction protects against arterial thrombosis models was not tested\",\n        \"Long-term safety of chronic hypofibrinogenemia in mice was not assessed\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealing non-hemostatic roles of FGA: FGA promotes angiogenesis in endometrial stromal cells via VEGFA–VEGFR2–FAK signaling, and in gastric cancer cells FGA transcriptionally represses ITGA5 to suppress FAK/ERK-mediated invasion and EMT while inducing autophagy.\",\n      \"evidence\": \"siRNA knockdown and overexpression, conditioned medium tube formation assays, ChIP and luciferase assays for ITGA5 promoter, xenograft models\",\n      \"pmids\": [\"35498401\", \"35257941\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether FGA acts intracellularly as a transcription co-regulator or via secreted autocrine signaling was not distinguished\",\n        \"The DNA-binding or chromatin-recruitment mechanism of FGA at the ITGA5 promoter was not characterized\",\n        \"These non-hemostatic functions have not been validated in FGA-knockout animal models\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connecting epigenetic regulation to FGA expression and ovarian function: HDAC2 maintains H3K9 acetylation and chromatin accessibility at the FGA promoter in granulosa cells, where FGA promotes proliferation and suppresses caspase-mediated apoptosis, affecting corpus luteum formation in vivo.\",\n      \"evidence\": \"HDAC2 siRNA, ATAC-seq, ChIP for H3K9ac at FGA promoter, flow cytometry for apoptosis, in vivo mouse experiments\",\n      \"pmids\": [\"40605115\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"How HDAC2 knockdown reduces acetylation (expected to increase it) requires mechanistic clarification\",\n        \"Whether FGA acts in granulosa cells via fibrinogen assembly or an independent mechanism is unknown\",\n        \"Single-lab finding not yet independently replicated\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis by which intracellular FGA influences transcription (e.g., at the ITGA5 promoter), whether non-hemostatic functions of FGA are fibrinogen-dependent or chain-autonomous, and whether partial fibrinogen reduction (as in Fga270 mice) can be therapeutically exploited for antithrombotic benefit in humans.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of FGA acting as a transcriptional regulator exists\",\n        \"Fibrinogen-independent versus fibrinogen-dependent signaling by FGA has not been dissected\",\n        \"Translation of the hypofibrinogenemia-as-antithrombotic concept to human clinical studies is lacking\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 4, 9, 10]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [14, 15, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 5, 8, 9, 13]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [0, 2, 5, 10, 13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [14, 15, 16]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 11, 15, 16]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"complexes\": [\n      \"Fibrinogen hexamer (Aα₂Bβ₂γ₂)\"\n    ],\n    \"partners\": [\n      \"FGB\",\n      \"FGG\",\n      \"VEGFA\",\n      \"ITGA5\",\n      \"HDAC2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"FGA encodes the fibrinogen Aα chain, an essential subunit of the (AαBβγ)₂ hexameric fibrinogen complex that is assembled in hepatocytes and secreted into plasma, where thrombin cleavage of fibrinopeptide A exposes the 'knob A' (Gly-Pro-Arg) polymerization site to initiate fibrin clot formation [PMID:7356959, PMID:9333233, PMID:19296670]. Loss-of-function mutations in FGA—including large deletions, splice-site mutations, and start-codon disruption—cause congenital afibrinogenemia, while missense mutations in the αC-region (e.g., E540V, R554L) confer amyloidogenicity and underlie hereditary renal amyloidosis, the most commonly misdiagnosed form of systemic amyloidosis [PMID:9916133, PMID:12050338, PMID:27126074]. FGA transcription in hepatocytes is driven by the PFE2 liver enhancer and regulated by HDAC2-dependent H3K9 acetylation at its promoter; FGA mRNA is produced in stoichiometric excess over FGB and FGG, with the γ chain being rate-limiting for fibrinogen secretion [PMID:22836734, PMID:23414568, PMID:40605115]. Beyond hemostasis, fibrinogen bridges leukocytes to endothelium via ICAM-1, and ectopic FGA expression suppresses cancer cell invasion by repressing ITGA5/FAK/ERK and PI3K/AKT signaling [PMID:8100742, PMID:35257941, PMID:39227068].\",\n  \"teleology\": [\n    {\n      \"year\": 1980,\n      \"claim\": \"Defining the structural basis of fibrin polymerization initiation: synthetic Gly-Pro-Arg peptides established that the newly exposed Aα N-terminus constitutes the 'knob A' donor site and defined the minimal sequence requirements for knob–hole interaction.\",\n      \"evidence\": \"Synthetic peptide binding and fibrin polymerization inhibition assays using purified fibrinogen\",\n      \"pmids\": [\"7356959\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Acceptor (hole) site structure not yet resolved\", \"In vivo relevance of peptide inhibition not tested\", \"Contribution of knob B not addressed\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing fibrinogen as a vascular adhesion bridge: fibrinogen was shown to mediate leukocyte–endothelial adhesion by engaging ICAM-1 as a novel fibrinogen receptor, expanding the Aα chain's role beyond coagulation to inflammation.\",\n      \"evidence\": \"Affinity chromatography, ICAM-1 transfectant binding assays, and adhesion blocking antibody experiments\",\n      \"pmids\": [\"8100742\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding site on Aα chain for ICAM-1 not mapped\", \"Relative contribution of Aα vs. Bβ/γ chains to ICAM-1 interaction unknown\", \"In vivo leukocyte trafficking consequences not tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Resolving the three-dimensional architecture of fibrinogen's functional domains: the crystal structure of fragment D and the double-D:Gly-Pro-Arg-Pro complex revealed the coiled-coil scaffold, globular D-domain topology, and the structural basis of knob–hole polymerization.\",\n      \"evidence\": \"X-ray crystallography at 2.9 Å resolution with polymerization-site peptide ligand\",\n      \"pmids\": [\"9333233\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length hexamer structure not yet available\", \"αC-region structure unresolved\", \"Dynamic conformational changes during polymerization not captured\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Proving FGA is essential for fibrinogen biogenesis in humans: an 11 kb homozygous FGA deletion was identified as the cause of congenital afibrinogenemia, and the deletion mechanism was traced to illegitimate recombination at a 7 bp direct repeat.\",\n      \"evidence\": \"Southern blotting, PCR, haplotype analysis of pedigrees; deletion junction sequencing across three independent chromosomes\",\n      \"pmids\": [\"9916133\", \"10602365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of individual FGA domains to intracellular assembly not dissected\", \"Non-hepatic consequences of complete FGA loss not explored\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Elucidating how FGA splice-site mutations produce null alleles: the most common afibrinogenemia mutation (IVS4+1G>T) activates cryptic splice donors causing frameshifts, and intron removal order determines whether a splice mutation causes exon skipping or cryptic-site usage.\",\n      \"evidence\": \"Minigene transfection in COS-7 cells with RT-PCR characterization of multiple mutations (IVS4, IVS3, IVS1)\",\n      \"pmids\": [\"11238133\", \"12406899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nonsense-mediated decay contribution not quantified at this stage\", \"Patient-to-patient variation in aberrant transcript ratios not assessed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identifying FGA mutations as the leading cause of hereditary renal amyloidosis: systematic screening of 350 patients revealed that Aα C-terminal variants are the most common genetic cause of systemic amyloidosis misdiagnosed as AL type.\",\n      \"evidence\": \"Genetic screening with histological and laboratory confirmation across a large patient cohort\",\n      \"pmids\": [\"12050338\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which αC variants convert to amyloid fibrils not established at molecular level\", \"Tissue tropism for kidney not explained\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Completing the hexameric fibrinogen structure: the full-length (AαBβγ)₂ crystal structure at 3.3 Å confirmed the coiled-coil arrangement, β-chain carbohydrate positions, and an antiparallel β-chain interface, though the αC domains remained unresolved.\",\n      \"evidence\": \"X-ray crystallography of intact human fibrinogen\",\n      \"pmids\": [\"19296670\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"αC-region remains structurally unresolved\", \"No structure of fibrinogen in complex with thrombin or cellular receptors\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defining cis-regulatory and mRNA-level control of FGA expression: the PFE2 enhancer was validated as a hepatocyte-specific element driving FGA transcription, and siRNA experiments demonstrated that FGA mRNA is in stoichiometric excess, with FGG being rate-limiting for fibrinogen secretion.\",\n      \"evidence\": \"Luciferase reporter assays in hepatoma cells; transgenic zebrafish GFP reporter; siRNA knockdown of each fibrinogen chain in HepG2 with secreted fibrinogen ELISA\",\n      \"pmids\": [\"22836734\", \"23414568\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcription factor(s) binding PFE2 not identified\", \"Post-transcriptional regulation of chain stoichiometry not addressed\", \"In vivo validation of stoichiometric excess in human liver lacking\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating FGA sufficiency for fibrinogen rescue: lentiviral delivery of FGA cDNA into afibrinogenemia patient hepatocytes restored functional hexamer secretion, and zebrafish fga knockouts recapitulated human afibrinogenemia with hemorrhage and lethality.\",\n      \"evidence\": \"Lentiviral transduction of patient hepatocytes with fibrinogen functional assays; zinc finger nuclease knockout zebrafish with hemorrhage scoring and survival analysis\",\n      \"pmids\": [\"25163824\", \"24553182\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo gene therapy efficacy and durability not assessed\", \"Long-term hemostatic function in zebrafish not followed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Establishing molecular mechanisms of amyloidogenic αC-region variants: in vitro aggregation of recombinant FGA(496-581) showed that E540V forms amyloid-like fibrils and R554L forms β-sheet-rich aggregates at physiological pH, while wild-type remains monomeric, directly linking point mutations to pathological misfolding.\",\n      \"evidence\": \"Recombinant fragment aggregation assays with AFM imaging and circular dichroism\",\n      \"pmids\": [\"27126074\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nucleation mechanism and kinetics not determined\", \"Kidney-specific amyloid deposition not explained\", \"No structural model of fibril at atomic resolution\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Uncoupling the αC-region from essential hemostatic function: mice with a premature stop at Aα residue 271 had ~10% plasma fibrinogen (via NMD) yet showed normal hemostasis, preserved platelet fibrinogen with compensatory fibronectin, and full protection from venous thrombosis—demonstrating that the αC-region is dispensable for hemostasis but critical for maintaining plasma fibrinogen levels.\",\n      \"evidence\": \"Targeted knock-in mouse; tail bleeding, laser injury, IVC stasis thrombosis, bacterial peritonitis models; platelet proteomics\",\n      \"pmids\": [\"34905618\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of platelet fibrinogen preservation not fully explained\", \"αC-region contribution to fibrin clot mechanical properties in vivo not tested\", \"Wound healing and tissue repair outcomes not evaluated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealing non-hemostatic signaling roles of FGA: in cancer cells, FGA represses ITGA5 transcription (via promoter binding) to suppress FAK/ERK signaling, migration, and invasion; in hepatocellular carcinoma, FGA loss activates PI3K/AKT; and in endometrial stromal cells, FGA promotes angiogenesis through a VEGFA-VEGFR2-FAK axis.\",\n      \"evidence\": \"FGA overexpression/knockout in gastric and hepatocellular carcinoma cells with ChIP, luciferase, xenograft models; siRNA in endometrial stromal cells with conditioned medium HUVEC assays\",\n      \"pmids\": [\"35257941\", \"39227068\", \"35498401\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether circulating fibrinogen or locally produced Aα chain mediates these effects is unclear\", \"Direct DNA-binding domain of FGA not identified\", \"Relevance to in vivo tumor biology in patients not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Linking epigenetic regulation to FGA's role in reproductive biology: HDAC2 was shown to control chromatin accessibility and H3K9ac at the FGA promoter in granulosa cells, where FGA promotes proliferation and suppresses apoptosis to support pubertal initiation.\",\n      \"evidence\": \"HDAC2 siRNA, ATAC-seq, ChIP for H3K9ac, FGA knockdown/overexpression in granulosa cells, in vivo mouse puberty model\",\n      \"pmids\": [\"40605115\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FGA functions intracellularly or as a secreted factor in granulosa cells is unknown\", \"Relationship between granulosa FGA and circulating fibrinogen not addressed\", \"Upstream signals regulating HDAC2 at FGA promoter not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the atomic structure of the αC-region and the structural basis of its amyloidogenic conversion; the mechanism by which FGA represses gene transcription (e.g., ITGA5) in non-hepatic cells; and whether therapeutic reduction of αC-region length can prevent thrombosis without hemostatic compromise in humans.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of the αC domain\", \"No identified DNA-binding or transcription-regulatory domain in FGA\", \"Clinical translation of αC-truncation antithrombotic strategy untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [4, 5, 6]},\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [7, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 5, 6, 7, 8, 18]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [0, 4, 5, 6, 14, 16, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 10]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [19, 20, 21]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [\n      \"Fibrinogen (AαBβγ)₂ hexamer\"\n    ],\n    \"partners\": [\n      \"FGB\",\n      \"FGG\",\n      \"ICAM1\",\n      \"ITGA5\",\n      \"VEGFR2\",\n      \"FAK\",\n      \"HDAC2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}